<SEC-DOCUMENT>0001193125-26-249684.txt : 20260601
<SEC-HEADER>0001193125-26-249684.hdr.sgml : 20260601
<ACCEPTANCE-DATETIME>20260601065636
ACCESSION NUMBER:		0001193125-26-249684
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20260529
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260601
DATE AS OF CHANGE:		20260601

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IN8BIO, INC.
		CENTRAL INDEX KEY:			0001740279
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				825462585
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39692
		FILM NUMBER:		261047071

	BUSINESS ADDRESS:	
		STREET 1:		EMPIRE STATE BUILDING
		STREET 2:		350 5TH AVENUE, SUITE 5330
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118
		BUSINESS PHONE:		(646) 600-6438

	MAIL ADDRESS:	
		STREET 1:		EMPIRE STATE BUILDING
		STREET 2:		350 5TH AVENUE, SUITE 5330
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Incysus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20180510
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d100941d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:inab="http://in8bio.com/20260529" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:srt="http://fasb.org/srt/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-320">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2026-05-29_to_2026-05-29">0001740279</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="inab-20260529.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2026-05-29_to_2026-05-29"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001740279</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2026-05-29</xbrli:startDate> <xbrli:endDate>2026-05-29</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-331">8-K</ix:nonNumeric></span></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt:datemonthdayyearen" id="ixv-332">May&#160;29, 2026</ix:nonNumeric></p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-333">IN8bio, Inc.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:stateprovnameen" id="ixv-334">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-335">001-39692</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-336">82-5462585</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(State or Other Jurisdiction<br/>of Incorporation)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr>
<tr style="font-size:1pt">
<td style="height:9.75pt"/>
<td style="height:9.75pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-337">350 5th Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-338">Suite 5330</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:top"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-339">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:stateprovnameen" id="ixv-340">New York</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-341">10118</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-342">(646)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-343">600-6438</ix:nonNumeric></span></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-344">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-345">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-346">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-347">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-348">Common Stock, $0.0001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-349">INAB</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:exchnameen" id="ixv-350">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#160;240.12b-2</span> of this chapter).</p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-351">&#9746;</ix:nonNumeric></p> <p style="margin-top:9pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;<ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="duration_2026-05-29_to_2026-05-29" format="ixt-sec:boolballotbox" id="ixv-352">&#9744;</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;1, 2026, IN8bio, Inc. (the &#8220;<span style="text-decoration:underline">Company</span>&#8221;) entered into a Capital on Demand<sup style="font-size:75%; vertical-align:top">TM</sup> Sales Agreement (the &#8220;<span style="text-decoration:underline">Sales Agreement</span>&#8221;) with JonesTrading Institutional Services LLC (the &#8220;<span style="text-decoration:underline">Agent</span>&#8221;) with respect to an at the market offering program under which the Company may issue and sell, from time to time at its sole discretion, shares (the &#8220;<span style="text-decoration:underline">Placement Shares</span>&#8221;) of its common stock, par value $0.0001 per share (the &#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;), through or to the Agent. The issuance and sale, if any, of the Placement Shares by the Company under the Sales Agreement will be made pursuant to the Company&#8217;s registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-291393),</span> as amended. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon delivery of a placement notice and subject to the terms and conditions of the Sales Agreement, the Agent may sell the Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 of the Securities Act of 1933, as amended, including, without limitation, sales made through The Nasdaq Capital Market or on any other existing trading market for the Common Stock. The Agent will use commercially reasonable efforts to sell the Placement Shares from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay the Agent a commission equal to an aggregate of three percent (3.0%) of the gross sales proceeds of any Placement Shares sold through the Agent under the Sales Agreement, and also has provided the Agent with customary indemnification and contribution rights. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is not obligated to make any sales of Common Stock under the Sales Agreement. The offering of Placement Shares pursuant to the Sales Agreement will terminate upon the earlier of (i)&#160;the issuance and sale of all Placement Shares subject to the Sales Agreement or (ii)&#160;termination of the Sales Agreement in accordance with its terms. The Company may terminate the Sales Agreement at any time upon ten (10)&#160;days written notice, and the Agent may terminate the Sales Agreement with at any time upon ten (10)&#160;days written notice or immediately upon the occurrence of certain specified events. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Sales Agreement is qualified in its entirety by reference to the full text of the Sales Agreement, which is attached as Exhibit 10.1 hereto and incorporated by reference herein. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cooley LLP, counsel to the Company, has issued a legal opinion relating to the Placement Shares. A copy of such legal opinion, including the consent included therein, is attached as Exhibit 5.1 hereto. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any offer, solicitation, or sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;1.02</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Termination of a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on November&#160;10, 2022 the Company entered into a Controlled Equity Offering<sup style="font-size:75%; vertical-align:top">SM</sup> Sales Agreement with Cantor Fitzgerald&#160;&amp; Co. (&#8220;<span style="text-decoration:underline">Cantor</span>&#8221;) as sales agent (the &#8220;<span style="text-decoration:underline">Cantor Sales Agreement</span>&#8221;), pursuant to which the Company was permitted to issue and sell, from time to time through Cantor, shares of the Company&#8217;s Common Stock. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On May&#160;29, 2026, the Company and Cantor mutually agreed to terminate the Cantor Sales Agreement and the offering of shares contemplated thereby, effective at the close of business on May&#160;29, 2026, pursuant to Sections 12(b) and 12(c) of the Cantor Sales Agreement. The Company and Cantor each waived the other party&#8217;s requirement in Sections 12(b) and 12(c) of the Cantor Sales Agreement to provide five (5)&#160;days&#8217; written notice to terminate the Cantor Sales Agreement. The Company is not subject to any termination penalties related to the termination of the Cantor Sales Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Following the termination of the Cantor Sales Agreement, the Company may not issue or sell any additional shares of its common stock under the Cantor Sales Agreement or the related prospectus. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Cantor Sales Agreement is not complete and is qualified in its entirety by reference to the full text of the Cantor Sales Agreement, a copy of which was filed as Exhibit 1.2 to the Company&#8217;s shelf registration statement on Form <span style="white-space:nowrap">S-3</span> filed with the SEC on November&#160;10, 2022 and declared effective by the SEC on November&#160;21, 2022, and which is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit<br/>No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#8199;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d100941dex51.htm">Opinion of Cooley LLP, dated June&#160;1, 2026. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d100941dex101.htm">Capital on Demand<sup style="font-size:75%; vertical-align:top">TM</sup> Sales Agreement, dated as of June&#160;1, 2026, by and between IN8bio, Inc. and JonesTrading Institutional Services LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d100941dex51.htm">Consent of Cooley LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">101</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">IN8bio, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: June&#160;1, 2026</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Patrick McCall</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">Patrick McCall</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Chief Financial Officer and Secretary</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">(Principal Financial and Accounting Officer)</span></p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d100941dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g100941g17t82.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jaime L. Chase </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">T: +1 202 728
7096 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">jchase@cooley.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;1, 2026 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN8bio, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">350 5th Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Suite 5330 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10118 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have acted as counsel to IN8bio, Inc.,
a Delaware corporation (the &#8220;<B><I>Company</I></B>&#8221;), in connection with the offering by the Company of shares of its common stock, par value $0.0001 per share (the &#8220;<B><I>Common Stock</I></B>&#8221;), having an aggregate offering
price of up to $2,800,000 (the &#8220;<B><I>Shares</I></B>&#8221;) pursuant to a Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-291393)</FONT> (the
&#8220;<B><I>Registration Statement</I></B>&#8221;) filed with the Securities and Exchange Commission (the &#8220;<B><I>Commission</I></B>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<B><I>Securities Act</I></B>&#8221;), the
prospectus included in the Registration Statement (the &#8220;<B><I>Base Prospectus</I></B>&#8221;) and the prospectus supplement relating to the Shares dated June&nbsp;1, 2026 filed with the Commission pursuant to Rule 424(b) under the Act
(together with the Base Prospectus, the &#8220;<B><I>Prospectus</I></B>&#8221;). The Shares are to be sold by the Company in accordance with that certain Capital on Demand<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> Sales Agreement, dated
June&nbsp;1, 2026, by and between the Company and JonesTrading Institutional Services LLC (the &#8220;<B><I>Agreement</I></B>&#8221;), as described in the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have examined and relied upon (a)&nbsp;the Registration Statement and the Prospectus, (b)&nbsp;the Agreement, (c)&nbsp;the
Company&#8217;s certificate of incorporation and bylaws, each as currently in effect, and (d)&nbsp;such other records, documents, opinions, certificates, memoranda and instruments as in our judgment are necessary or appropriate to enable us to
render the opinion expressed below. We have assumed the genuineness all signatures; the authenticity of all documents submitted to us as originals; the conformity to originals of all documents submitted to us as copies; the accuracy, completeness
and authenticity of certificates of public officials and the due authorization, execution and delivery, of all documents by all persons other than the Company. As to certain factual matters, we have relied upon a certificate of an officer of the
Company and have not independently verified such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have assumed (i)&nbsp;that each sale of Shares will be duly authorized by the Board of
Directors of the Company, a duly authorized committee thereof or a person or body pursuant to an authorization granted in accordance with Section&nbsp;152 of the General Corporation Law of the State of Delaware (the
&#8220;<B><I>DGCL</I></B>&#8221;), (ii) that no more than 15,000,000 Shares will be sold under the Agreement pursuant to the Prospectus and (iii)&nbsp;that the price at which the Shares are sold will equal or exceed the par value of the Shares. We
express no opinion to the extent that future issuances of securities of the Company, anti-dilution adjustments to outstanding securities of the Company or other matters cause the number of shares of Common Stock issuable under the Agreement to
exceed the number of shares of Common Stock available for issuance by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is expressed solely with respect to the DGCL. We express
no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law, rule or regulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COOLEY LLP 1299
PENNSYLVANIA AVE., WASHINGTON DC 20004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">T: (212) 842-7800 F: (202) 842-7899 COOLEY.COM </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g100941g17t82.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN8bio, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 1, 2026
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Two </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the foregoing, in reliance thereon and subject to the qualifications set forth herein, we are
of the opinion that the Shares, when sold and issued against payment therefor in accordance with the Agreement, the Registration Statement and the Prospectus, will be validly issued, fully paid and nonassessable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This opinion is limited to the matters expressly set forth in this letter, and no opinion should be implied, or may be inferred, beyond the matters expressly
stated. This opinion speaks only as to law and facts in effect or existing as of the date hereof, and we have no obligation or responsibility to update or supplement this letter to reflect any facts or circumstances that may hereafter come to our
attention or any changes in law that may hereafter occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the heading &#8220;Legal Matters&#8221; in the
Prospectus and to the filing of this opinion as an exhibit to the Company&#8217;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> to be filed with the Commission for incorporation by reference into the Registration Statement. In
giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act, or the rules and regulations of the Commission thereunder. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cooley LLP</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Jaime L. Chase</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jaime L. Chase</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">COOLEY LLP 1299
PENNSYLVANIA AVE., WASHINGTON DC 20004 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">T: (212) 842-7800 F: (202) 842-7899 COOLEY.COM </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>d100941dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IN8bio, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Common Stock
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">($0.0001 par value per share) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Capital on Demand<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Sales Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">June&nbsp;1, 2026 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JonesTrading Institutional
Services LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">325 Hudson Street., 6th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY
10013 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN8bio, Inc.,
a Delaware corporation (the &#8220;<U>Company</U>&#8221;), confirms its agreement (this &#8220;<U>Agreement</U>&#8221;) with JonesTrading Institutional Services LLC (the &#8220;<U>Agent</U>&#8221;), as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Issuance and Sale of Shares</U>. The Company agrees that, from time to time during the term of this Agreement, on the terms and subject
to the conditions set forth herein, it may issue and sell through or to the Agent, as agent or principal, shares (the &#8220;<U>Placement Shares</U>&#8221;) of common stock of the Company, $0.0001 par value per share (the &#8220;<U>Common
Stock</U>&#8221;), <I>provided, however</I>, that in no event shall the Company issue or sell, through or to Agent, Placement Shares for an aggregate gross sales proceeds that would exceed (a)&nbsp;the dollar amount of shares of Common Stock
registered on the Registration Statement (as defined below), (b) the number of authorized but unissued shares of Common Stock, or (c)&nbsp;dollar amount of shares of Common Stock permitted to be sold under Form
<FONT STYLE="white-space:nowrap">S-3,</FONT> including General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> if applicable, or (iv)&nbsp;the dollar amount of shares of Common Stock for which the Company has filed a
Prospectus (as defined below) (the least of (i), (ii), (iii) and (iv), the &#8220;<U>Maximum Amount</U>&#8221;). Notwithstanding anything to the contrary contained herein, the parties hereto agree that compliance with the limitations set forth in
this Section&nbsp;1 on the amount of Placement Shares issued and sold under this Agreement shall be the sole responsibility of the Company and that Agent shall have no obligation in connection with such compliance. The issuance and sale of Placement
Shares hereunder will be effected pursuant to the Registration Statement and at no earlier time than such time as the Registration Statement shall have been declared effective by the Securities and Exchange Commission (the
&#8220;<U>Commission</U>&#8221;), although nothing in this Agreement shall be construed as requiring the Company to issue any Placement Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date hereof, the Company has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and
regulations thereunder (the &#8220;<U>Securities Act</U>&#8221;), with the Commission a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> <FONT STYLE="white-space:nowrap">(333-291393),</FONT> including a base prospectus,
relating to certain securities, including the Placement Shares to be issued from time to time by the Company, and which incorporates by reference documents that the Company has filed or will file in accordance with the provisions of the Securities
Exchange Act of 1934, as amended, and the rules and regulations thereunder (the &#8220;<U>Exchange Act</U>&#8221;). The Company has prepared a prospectus supplement to the base prospectus included as part of the registration statement
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
specifically relating to the Placement Shares (the &#8220;<U>Prospectus Supplement</U>&#8221;). The Company will furnish to the Agent, for use by the Agent, copies of the base prospectus included
as part of such registration statement, as supplemented by the Prospectus Supplement, relating to the Placement Shares. Except where the context otherwise requires, such registration statement, and any post-effective amendment thereto, including all
documents filed as part thereof or incorporated by reference therein, and including any information contained in a Prospectus (as defined below) subsequently filed with the Commission pursuant to Rule&nbsp;424(b) under the Securities Act or deemed
to be a part of such registration statement pursuant to Rule&nbsp;430B or 462(b) under the Securities Act or any subsequent registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> filed pursuant to Rule 415(a)(6) under the
Securities Act by the Company to cover any Placement Shares, as a result of the end of the three-year period described in Rule 415(a)(5) of the Securities Act, is herein called the &#8220;<U>Registration Statement</U>.&#8221; The base prospectus,
including all documents incorporated therein by reference, to the extent such information has not been superseded or modified in accordance with Rule 412 under the Securities Act (as qualified by Rule 430B(g) of the Securities Act), included in the
Registration Statement, as it may be supplemented by one or more prospectus supplements, in the form in which such Prospectus Supplement has most recently been filed by the Company with the Commission pursuant to Rule&nbsp;424(b) under the
Securities Act, together with any then issued Issuer Free Writing Prospectus (defined below), is herein called the &#8220;<U>Prospectus</U>.&#8221;<B> </B>Any reference herein to the Registration Statement, the Prospectus or any amendment or
supplement thereto shall be deemed to refer to and include the documents incorporated by reference therein, and any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the
Registration Statement or the Prospectus shall be deemed to refer to and include the filing after the execution hereof of any document with the Commission deemed to be incorporated by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference herein to the Registration Statement, the Prospectus Supplement, the Prospectus or any Issuer Free Writing Prospectus shall be
deemed to refer to and include the documents, if any, incorporated by reference therein (the &#8220;<U>Incorporated Documents</U>&#8221;), including, unless the context otherwise requires, the documents, if any, filed as exhibits to such
Incorporated Documents. Any reference herein to the terms &#8220;amend,&#8221; &#8220;amendment&#8221; or &#8220;supplement&#8221; with respect to the Registration Statement, the Prospectus Supplement, the Prospectus or any Issuer Free Writing
Prospectus shall be deemed to refer to and include the filing of any document under the Exchange Act on or after the most-recent effective date of the Registration Statement, or the date of the Prospectus or such Issuer Free Writing Prospectus, as
the case may be, and incorporated therein by reference. For purposes of this Agreement, all references to the Registration Statement, the Prospectus or to any amendment or supplement thereto shall be deemed to include any copy filed with the
Commission pursuant to its Electronic Data Gathering Analysis and Retrieval system, or if applicable, the Interactive Data Electronic Application system when used by the Commission (collectively, &#8220;<U>EDGAR</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Placements</U>. Each time that the Company wishes to issue and sell Placement Shares hereunder (each, a &#8220;<U>Placement</U>&#8221;),
it will notify the Agent by email notice (or other method mutually agreed to in writing by the Parties) of the number or dollar value of Placement Shares to be sold, the time period during which sales are requested to be made, any limitation on the
number of Placement Shares that may be sold in any one Trading Day and any minimum price below which sales may not be made (a &#8220;<U>Placement Notice</U>&#8221;), the form of which is attached hereto as Schedule 1. The Placement Notice shall
originate from any of the individuals from the Company set forth </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
on Schedule 3 (with a copy to each of the other individuals from the Company listed on such schedule), and shall be addressed to each of the individuals from the Agent set forth on Schedule 3, as
such Schedule 3&nbsp;may be amended from time to time. The Placement Notice shall be effective unless and until (i)&nbsp;the Agent declines to accept the terms contained therein for any reason, in its sole discretion, (ii)&nbsp;the entire amount of
the Placement Shares to be sold thereunder have been sold, (iii)&nbsp;the Company suspends or terminates the Placement Notice for any reason, in its sole discretion, (iv)&nbsp;the Company issues a subsequent Placement Notice with parameters
superseding those of the earlier dated Placement Notice, or (v)&nbsp;this Agreement has been terminated under the provisions of Section&nbsp;12. The amount of any discount, commission or other compensation to be paid by the Company to the Agent in
connection with the sale of the Placement Shares shall be calculated in accordance with the terms set forth in Schedule 2. It is expressly acknowledged and agreed that neither the Company nor the Agent will have any obligation whatsoever with
respect to a Placement or any Placement Shares unless and until the Company delivers a Placement Notice to the Agent and the Agent does not decline such Placement Notice pursuant to the terms set forth above, and then only upon the terms specified
therein and herein. In the event of a conflict between the terms of this Agreement and the terms of a Placement Notice, the terms of the Placement Notice will control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Sale of Placement Shares by the Agent</U>. Subject to the provisions of <U>Section</U><U></U><U>&nbsp;5(a)</U>, the Agent, for the
period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices and applicable state and federal laws, rules and regulations and the rules of the Nasdaq Stock Market LLC
(the &#8220;<U>Exchange</U>&#8221;), to sell the Placement Shares up to the amount specified in, and otherwise in accordance with the terms of such Placement Notice. The Agent will provide written confirmation to the Company no later than the
opening of the Trading Day immediately following the Trading Day on which it has made sales of Placement Shares hereunder setting forth the number of Placement Shares sold on such day, the compensation payable by the Company to the Agent pursuant to
<U>Section</U><U></U><U>&nbsp;2</U> with respect to such sales, and the Net Proceeds (as defined below) payable to the Company, with an itemization of the deductions made by the Agent (as set forth in <U>Section</U><U></U><U>&nbsp;5(b)</U>) from the
gross proceeds that it receives from such sales. Subject to the terms of the Placement Notice, the Agent may sell Placement Shares by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule&nbsp;415(a)(4)
under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Suspension of Sales</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company or the Agent may, upon notice to the other party in writing (including by email correspondence to each of the individuals of
the other party set forth on Schedule 3, if receipt of such correspondence is actually acknowledged by any of the individuals to whom the notice is sent, other than via auto-reply) or by telephone (confirmed immediately by verifiable facsimile
transmission or email correspondence to each of the individuals of the other party set forth on Schedule 3), suspend any sale of Placement Shares; <I>provided, however</I>, that such suspension shall not affect or impair any party&#8217;s
obligations with respect to any Placement Shares sold hereunder prior to the receipt of such notice. While a suspension is in effect any obligation under Sections 7(l), 7(m) and 7(n) with respect to the delivery of certificates, opinions, or comfort
letters to the Agent shall be waived. Each party agrees that no such notice under this Section&nbsp;4 shall be effective against any other party unless it is made to one of the individuals named on Schedule 3 hereto as associated with such other
party, as such Schedule may be amended in writing from time to time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Sale and Delivery to the Agent; Settlement</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Sale of Placement Shares</U><I>. </I>On the basis of the representations and warranties herein contained and subject to the terms and
conditions herein set forth, upon the Agent&#8217;s acceptance of the terms of a Placement Notice, and unless the sale of the Placement Shares described therein has been declined, suspended, or otherwise terminated in accordance with the terms of
this Agreement, the Agent, for the period specified in the Placement Notice, will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell such Placement Shares up to the amount specified in such
Placement Notice, and otherwise in accordance with the terms of such Placement Notice. The Company acknowledges and agrees that (i)&nbsp;there can be no assurance that the Agent will be successful in selling Placement Shares, (ii)&nbsp;the Agent
will incur no liability or obligation to the Company or any other person or entity if it does not sell Placement Shares for any reason other than a failure by the Agent to use its commercially reasonable efforts consistent with its normal trading
and sales practices and applicable law and regulations to sell such Placement Shares as required under this Agreement and (iii)&nbsp;the Agent shall be under no obligation to purchase Placement Shares on a principal basis pursuant to this Agreement,
except as otherwise agreed by the Agent and the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Settlement of Placement Shares</U><I>. </I>Unless otherwise specified in
the applicable Placement Notice, settlement for sales of Placement Shares will occur on the first (1<SUP STYLE="font-size:75%; vertical-align:top">st</SUP>) Trading Day (or such earlier day as is industry practice for
<FONT STYLE="white-space:nowrap">regular-way</FONT> trading) following the date on which such sales are made (each, a &#8220;<U>Settlement Date</U>&#8221;). The Agent shall notify the Company of each sale of Placement Shares no later than the
opening of the Trading Day immediately following the Trading Day on which it has made sales of Placement Shares hereunder. The amount of proceeds to be delivered to the Company on a Settlement Date against receipt of the Placement Shares sold (the
&#8220;<U>Net Proceeds</U>&#8221;) will be equal to the aggregate sales price received by the Agent, after deduction for (i)&nbsp;the Agent&#8217;s commission, discount or other compensation for such sales payable by the Company pursuant to
Section&nbsp;2 hereof, and (ii)&nbsp;any transaction fees imposed by any governmental or self-regulatory organization in respect of such sales. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I></I><U>Delivery of Placement Shares</U>. On or before each Settlement Date, the Company will, or will cause its transfer agent to,
electronically transfer the Placement Shares being sold by crediting the Agent&#8217;s or its designee&#8217;s account (provided the Agent shall have given the Company written notice of such designee at least one Trading Day prior to the Settlement
Date) at The Depository Trust Company through its Deposit and Withdrawal at Custodian System or by such other means of delivery as may be mutually agreed upon by the parties hereto which in all cases shall be freely tradable, transferable,
registered shares in good deliverable form. On each Settlement Date, the Agent will deliver the related Net Proceeds in same day funds to an account designated by the Company on, or prior to, the Settlement Date. The Company agrees that if the
Company, or its transfer agent (if applicable), defaults in its obligation to deliver Placement Shares on a Settlement Date through no fault of the Agent, the Company agrees that in addition to and in no way limiting the rights and obligations set
forth in Section&nbsp;10(a) hereto, it will (i)&nbsp;hold the Agent harmless against any loss, claim, damage, or reasonable and documented expense (including reasonable and documented legal fees and expenses), as incurred, arising out of or in
connection with such default by the Company or its transfer agent (if applicable) and (ii)&nbsp;pay to the Agent (without duplication) any commission, discount, or other compensation to which it would otherwise have been entitled absent such
default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Limitations on Offering Size</U><I>. </I>Under no circumstances shall the Company
cause or request the offer or sale of any Placement Shares if, after giving effect to the sale of such Placement Shares, the aggregate gross sales proceeds of Placement Shares sold pursuant to this Agreement would exceed the lesser of
(A)&nbsp;together with all sales of Placement Shares under this Agreement, the Maximum Amount and (B)&nbsp;the amount authorized from time to time to be issued and sold under this Agreement by the Company&#8217;s board of directors, a duly
authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing. Under no circumstances shall the Company cause or request the offer or sale of any Placement Shares pursuant to this Agreement at a price
lower than the minimum price authorized from time to time by the Company&#8217;s board of directors, duly authorized committee thereof or a duly authorized executive committee, and notified to the Agent in writing. Further, under no circumstances
shall the Company cause or permit the aggregate gross sales proceeds of Placement Shares sold pursuant to this Agreement to exceed the Maximum Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Representations and Warranties of the Company</U>. Except as disclosed in the Registration Statement or Prospectus (including the
Incorporated Documents), the Company represents and warrants to, and agrees with the Agent that as of the date of this Agreement and as of each Applicable Time (as defined below), unless such representation, warranty or agreement specifies
otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement and Prospectus</U>. As of the date of this Agreement, the Company and the transactions
contemplated by this Agreement meet the requirements for and comply with the conditions for the use of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act. The Registration Statement has been or will be filed with the
Commission and has been or will be declared effective by the Commission under the Securities Act prior to the issuance of any Placement Notice by the Company. The Prospectus Supplement will name Agent as agent, in the section entitled &#8220;Plan of
Distribution.&#8221; The Company has not received, and has no notice of, any order of the Commission preventing or suspending the use of the Registration Statement, or threatening or instituting proceedings for that purpose. The Registration
Statement and the offer and sale of Placement Shares as contemplated hereby meet the applicable requirements of Rule&nbsp;415 under the Securities Act and comply in all material respects with the applicable requirements of said Rule. Any statutes,
regulations, contracts or other documents that are required to be described in the Registration Statement or the Prospectus or to be filed as exhibits to the Registration Statement have been or will be so described or filed. Copies of the
Registration Statement, the Prospectus, and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior to the date of this Agreement have been delivered, or are available
through EDGAR, to the Agent and its counsel. The Company has not distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Placement Shares, will not distribute any offering material in connection
with the offering or sale of the Placement Shares other than the Registration Statement and the Prospectus and any Issuer Free Writing Prospectus to which the Agent has consented. The Company has taken no action designed to, or likely to have the
effect of, terminating the registration of the Common Stock under the Exchange Act, delisting the Common Stock from the Exchange, nor has the Company received any notification that the Commission or the Exchange is contemplating terminating such
registration or listing. To the Company&#8217;s knowledge, it is in compliance with all applicable listing requirements of the Exchange. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Misstatement or Omission</U>. The Registration Statement, when it became or
becomes effective, and the Prospectus, any Issuer Free Writing Prospectus and any amendment or supplement thereto, on the date of such Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements
of the Securities Act. At each Settlement Date, the Registration Statement and the Prospectus, as of such date, will conform in all material respects with the requirements of the Securities Act. The Registration Statement, when it became or becomes
effective, did not, and will not, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; <I>provided, however</I>, that no
representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance upon and in conformity with information furnished to the Company by or through the Agent specifically for inclusion therein. The
Prospectus and any amendment or supplement thereto, on the date thereof and at each Applicable Time (defined below), did not and will not include an untrue statement of a material fact or omit to state a material fact necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. The documents incorporated by reference in the Prospectus did not, and any further documents filed and incorporated by reference therein will not, when
filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they
were made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and in conformity with, information furnished to the Company by Agent specifically for use in the preparation
thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Financial Information</U>. The financial statements of the Company included or incorporated by reference in the
Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, together with the related notes and schedules, present fairly, in all material respects, the financial position of the Company and the Subsidiaries (as defined
below) as of the dates indicated and the results of operations, cash flows and changes in stockholders&#8217; equity of the Company and the Subsidiaries for the periods specified (subject, in the case of unaudited interim financial statements, to
normal <FONT STYLE="white-space:nowrap">year-end</FONT> audit adjustments) and have been prepared in compliance with the requirements of the Securities Act and Exchange Act and in conformity with GAAP (as defined below) applied on a consistent basis
(except for (i)&nbsp;such adjustments to accounting standards and practices as are noted therein, (ii)&nbsp;in the case of unaudited interim financial statements, to the extent such financial statements may not include footnotes required by GAAP or
may be condensed or summary statements and (iii)&nbsp;such adjustments which will not be material, either individually or in the aggregate) during the periods involved. There are no financial statements that are required to be included or
incorporated by reference in the Registration Statement or the Prospectus that are not included or incorporated by reference as required; the Company and the Subsidiaries do not have any material liabilities or obligations, direct or contingent
(including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), not described in the Registration Statement (excluding the exhibits thereto), and the Prospectus. All disclosures contained or incorporated by reference in the
Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, regarding <FONT STYLE="white-space:nowrap">&#8220;non-GAAP</FONT> financial measures&#8221; (as such term is defined by the rules and regulations of the
Commission) comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, to the extent applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Conformity with EDGAR Filing</U>. The Prospectus delivered to the Agent for use in
connection with the sale of the Placement Shares pursuant to this Agreement will be identical to the versions of the Prospectus created to be transmitted to the Commission for filing via EDGAR, except to the extent permitted by Regulation <FONT
STYLE="white-space:nowrap">S-T.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Organization</U>. The Company and its Subsidiaries, if any, are, and will be, duly
organized, validly existing as a corporation and in good standing under the laws of their respective jurisdictions of organization. Each of the Company and the Subsidiaries is duly licensed or qualified as a foreign corporation for transaction of
business and in good standing under the laws of each other jurisdiction in which its ownership or lease of property or the conduct of its business requires such license or qualification, and has all corporate power and authority necessary to own or
hold its properties and to conduct its business as described in the Registration Statement and the Prospectus, except where the failure to be so qualified or in good standing or have such power or authority would not, individually or in the
aggregate, have a material adverse effect or would reasonably be expected to have a material adverse effect on or affecting the assets, business, operations, earnings, properties, condition (financial or otherwise), prospects, stockholders&#8217;
equity or results of operations of the Company and the Subsidiaries taken as a whole, or prevent or materially interfere with consummation of the transactions contemplated hereby (a &#8220;<U>Material Adverse Effect</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Subsidiaries</U>. The Company&#8217;s only Subsidiaries, if any, are set forth on Exhibit 21.1 to the Company&#8217;s Annual Report on
Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the most recently ended fiscal year, other than any Subsidiaries formed or acquired after the date of filing of such Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> The
Company owns directly or indirectly, all of the equity interests of the Subsidiaries free and clear of any lien, charge, security interest, encumbrance, right of first refusal or other restriction, and all the equity interests of the Subsidiaries
are validly issued and are fully paid, nonassessable and free of preemptive and similar rights. As of the date hereof, the Company does not have any Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>No Violation or Default</U>. Neither the Company nor any Subsidiary is (i)&nbsp;in violation of its charter or <FONT
STYLE="white-space:nowrap">by-laws</FONT> or similar organizational documents; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any
term, covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of
the property or assets of the Company or any Subsidiary is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case
of each of clauses (ii)&nbsp;and (iii) above, for any such violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. To the Company&#8217;s knowledge, no other party under any material contract or other
agreement to which it or any Subsidiary is a party is in default in any respect thereunder where such default would not be reasonably expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>No Material Adverse Effect</U>. Subsequent to the latest date of which information is
given in the Registration Statement, the Prospectus and the Issuer Free Writing Prospectuses, if any, (including any document deemed incorporated by reference therein), there has not been (i)&nbsp;any Material Adverse Effect or the occurrence of any
development that the Company reasonably expects will result in a Material Adverse Effect, (ii)&nbsp;any transaction which is material to the Company and the Subsidiaries taken as a whole, (iii)&nbsp;any obligation or liability, direct or contingent
(including any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet obligations), incurred by the Company or the Subsidiaries which is material to the Company and the Subsidiaries taken as a whole, (iv)&nbsp;any material change in the capital
stock or outstanding long-term indebtedness of the Company or the Subsidiaries (other than (A)&nbsp;the grant of awards under equity incentive plans, (B)&nbsp;changes in the number of shares of outstanding Common Stock due to exercise or conversion
of securities exercisable for or convertible into Common Stock described in the Registration Statement (including any document deemed incorporated by reference therein), (C) any repurchase of capital stock of the Company, (D)&nbsp;as a result of the
sale of Placement Shares or (E)&nbsp;other than as publicly reported or announced) or (v)&nbsp;any dividend or distribution of any kind declared, paid or made on the capital stock of the Company or any Subsidiary, other than in each case above in
the ordinary course of business or as otherwise disclosed in the Registration Statement or Prospectus (including any document deemed incorporated by reference therein). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Capitalization</U>. The issued and outstanding shares of capital stock of the Company have been validly issued, are fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> and, other than as disclosed in the Registration Statement or the Prospectus, are not subject to any preemptive rights, rights of first refusal or similar rights. The Company has an authorized, issued
and outstanding capitalization as set forth in the Registration Statement and the Prospectus as of the dates referred to therein (other than the grant of options and restricted stock units under the Company&#8217;s equity incentive plans, or changes
in the number of outstanding shares of Common Stock of the Company due to the issuance of shares upon the exercise or conversion of securities exercisable for, or convertible into, Common Stock described in the Registration Statement or Prospectus)
and such authorized capital stock conforms in all material respects to the description thereof set forth in the Registration Statement and the Prospectus. The description of the securities of the Company in the Registration Statement and the
Prospectus is complete and accurate in all material respects. Except as disclosed in the Registration Statement or the Prospectus, as of the date as of the date of the most recent balance sheet included or incorporated by reference therein, the
Company does not have outstanding any options to purchase, or any rights or warrants to subscribe for, or any securities or obligations convertible into, or exchangeable for, or any contracts or commitments to issue or sell, any shares of capital
stock or other securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Authorization; Enforceability</U>. The Company has full legal right, power and authority to enter into
this Agreement and perform the transactions contemplated hereby. This Agreement has been duly authorized, executed and delivered by the Company and is a legal, valid and binding agreement of the Company enforceable in accordance with its terms,
except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general equitable principles or by federal or state securities laws or
public policy considerations with respect to provisions for indemnification or limitations of liability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Authorization of Placement Shares</U>. The Placement Shares, when issued and
delivered pursuant to the terms approved by the board of directors of the Company or a duly authorized committee thereof, against payment therefor as provided herein, will be duly authorized, validly issued and fully paid and <FONT
STYLE="white-space:nowrap">non-assessable,</FONT> free and clear of any pledge, lien, encumbrance, security interest or other claim, including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar
rights, and will be registered pursuant to Section&nbsp;12 of the Exchange Act. The Placement Shares, when issued, will conform in all material respects to the description thereof set forth in or incorporated into the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>No Consents Required</U>. No consent, approval, authorization, order, registration or qualification of or with any court or arbitrator
or governmental or regulatory authority having jurisdiction over the Company is required for the execution, delivery and performance by the Company of this Agreement or the issuance and sale by the Company of the Placement Shares, except for such
consents, approvals, authorizations, orders, registrations or qualifications as have been obtained or may be required under applicable state securities laws or by the <FONT STYLE="white-space:nowrap">by-laws</FONT> and rules of the Financial
Industry Regulatory Authority (&#8220;<U>FINRA</U>&#8221;) or the Exchange in connection with the sale of the Placement Shares by the Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>No Preferential Rights</U>. (i)&nbsp;No person, as such term is defined in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of
Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> promulgated under the Securities Act (each, a &#8220;<U>Person</U>&#8221;), has the right, contractual or otherwise, to cause the Company to issue or sell to such Person any Common Stock or
shares of any other capital stock or other securities of the Company (other than upon the exercise of options or warrants to purchase Common Stock), (ii)&nbsp;no Person has any preemptive rights, resale rights, rights of first refusal, or any other
rights (whether pursuant to a &#8220;poison pill&#8221; provision or otherwise) to purchase any Common Stock or shares of any other capital stock or other securities of the Company, (iii)&nbsp;no Person has the right to act as an underwriter or as a
financial advisor to the Company in connection with the offer and sale of the Placement Shares, and (iv)&nbsp;no Person has the right, contractual or otherwise, to require the Company to register under the Securities Act any Common Stock or shares
of any other capital stock or other securities of the Company, or to include any such shares or other securities in the Registration Statement or the offering contemplated thereby, whether as a result of the filing or effectiveness of the
Registration Statement or the sale of the Placement Shares as contemplated thereby or otherwise, except for such rights as have been or will be satisfied or duly waived on or prior to the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Independent Public Accountant</U>. The Company&#8217;s accountants, whose report on the financial statements of the Company is filed
with the Commission as part of the Company&#8217;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> filed with the Commission and incorporated by reference into the Registration Statement and the Prospectus, are and,
during the periods covered by their report, were an independent registered public accounting firm with respect to the Company within the meaning of the Securities Act and the Public Company Accounting Oversight Board (United States). To the
Company&#8217;s knowledge, the Company&#8217;s accountants are not in violation of the auditor independence requirements of the Sarbanes-Oxley Act of 2002 (the &#8220;<U>Sarbanes-Oxley Act</U>&#8221;) with respect to the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Enforceability of Agreements</U>. All agreements between the Company and third
parties expressly referenced in the Prospectus, other than such agreements that have expired by their terms or the termination of which is disclosed in documents filed by the Company on EDGAR, are legal, valid and binding obligations of the Company
enforceable in accordance with their respective terms, except to the extent that (i)&nbsp;enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors&#8217; rights generally and by general
equitable principles and (ii)&nbsp;the indemnification provisions of certain agreements may be limited by federal or state securities laws or public policy considerations in respect thereof; except for any unenforceability that, individually or in
the aggregate, would not reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>No Litigation</U>. There are no legal,
governmental or regulatory actions, suits or proceedings pending, nor, to the Company&#8217;s knowledge, any legal, governmental or regulatory investigations, to which the Company or any Subsidiary is a party or to which any property of the Company
or any Subsidiary is the subject that, individually or in the aggregate, if determined adversely to the Company or any Subsidiary, would reasonably be expected to have a Material Adverse Effect or materially and adversely affect the ability of the
Company to perform its obligations under this Agreement; to the Company&#8217;s knowledge, no such actions, suits or proceedings are threatened or contemplated by any governmental or regulatory authority or threatened by others that, individually or
in the aggregate, if determined adversely to the Company or any Subsidiary, would reasonably be expected to have a Material Adverse Effect; and (i)&nbsp;there are no current or pending legal, governmental or regulatory audits or investigations,
actions, suits or proceedings that are required under the Securities Act to be described in the Prospectus that are not so described; and (ii)&nbsp;there are no contracts or other documents that are required under the Securities Act to be filed as
exhibits to the Registration Statement that are not so filed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <U>Licenses and Permits</U>. The Company and the Subsidiaries have made
all filings, applications and submissions required by, possesses and is operating in compliance with, all approvals, licenses, certificates, consents, orders, permits and other authorizations issued by, and have made all declarations and filings
with, the appropriate federal, state, local or foreign governmental or regulatory authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration
Statement and the Prospectus (the &#8220;<U>Permits</U>&#8221;), except where the failure to possess, obtain or make the same would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Company
nor any Subsidiary has received written notice of any proceeding relating to revocation or modification of any such Permit or has any reason to believe that such Permit will not be renewed in the ordinary course, except where the failure to obtain
any such renewal would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <U>Regulatory Filings</U>. The Company
has not failed to file with the applicable regulatory authorities any required filing, declaration, listing, registration, report or submission, except for such failures that, individually or in the aggregate, would not reasonably be expected to
have a Material Adverse Effect; all such filings, declarations, listings, registrations, reports or submissions were in compliance with applicable laws when filed and no deficiencies have been asserted by any applicable regulatory authority with
respect to any such filings, declarations, listings, registrations, reports or submissions, except for any deficiencies that, individually or in the aggregate, would not have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) <U>Market Capitalization</U>. At the time the Registration Statement was or will be
declared effective, and at the time the Company&#8217;s most recent Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> was filed with the Commission, the Company met or will meet the then applicable requirements for the use of Form <FONT
STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, including, but not limited to, General Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3,</FONT> if applicable. The aggregate market value&nbsp;of the outstanding voting
and <FONT STYLE="white-space:nowrap">non-voting</FONT> common equity (as defined in Securities Act Rule 405) of the Company held by persons other than affiliates of the Company (pursuant to Securities Act Rule 144, those that directly, or indirectly
through one or more intermediaries, control, or are controlled by, or are under common control with, the Company)&nbsp;(the &#8220;<U><FONT STYLE="white-space:nowrap">Non-Affiliate</FONT> Shares</U>&#8221;), was equal to $17,932,668 (calculated by
multiplying (x)&nbsp;the highest price at which the common equity of the Company closed on the Exchange on May&nbsp;29, 2026 times (y)&nbsp;the number of <FONT STYLE="white-space:nowrap">Non-Affiliate</FONT> Shares). The Company is not a shell
company (as defined in Rule 405 under the Securities Act) and has not been a shell company for at least 12 calendar months previously and if it has been a shell company at any time previously, has filed current Form 10 information (as defined in
Instruction I.B.6 of Form <FONT STYLE="white-space:nowrap">S-3)</FONT> with the Commission at least 12 calendar months previously reflecting its status as an entity that is not a shell company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) <U>No Material Defaults</U>. Neither the Company nor any Subsidiary has defaulted on any installment on indebtedness for borrowed money or
on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. The Company has not filed a report pursuant to Section&nbsp;13(a) or 15(d) of the
Exchange Act since the filing of its last Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> indicating that it (i)&nbsp;has failed to pay any dividend or sinking fund installment on preferred stock or (ii)&nbsp;has defaulted on any
installment on indebtedness for borrowed money or on any rental on one or more long-term leases, which defaults, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) <U>Certain Market Activities</U>. Neither the Company, any Subsidiary nor any of its directors, officers or controlling persons has taken,
directly or indirectly, any action designed, or that has constituted or would reasonably be expected to cause or result in, under the Exchange Act or otherwise, the stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Broker/Dealer Relationships</U>. Neither the Company, any of its
Subsidiaries, nor any of the Company&#8217;s affiliates (i)&nbsp;is required to register as a &#8220;broker&#8221; or &#8220;dealer&#8221; in accordance with the provisions of the Exchange Act or (ii)&nbsp;directly or indirectly through one or more
intermediaries, controls or is a &#8220;person associated with a member&#8221; or &#8220;associated person of a member&#8221; (within the meaning set forth in the rules and regulations of FINRA). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) <U>No Reliance</U>. The Company has not relied upon the Agent or legal counsel for the Agent for any legal, tax or accounting advice in
connection with the offering and sale of the Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) <U>Taxes</U>. The Company and the Subsidiaries have filed all federal,
state, local and foreign tax returns which have been required to be filed and paid all taxes shown thereon through the date hereof, to the extent that such taxes have become due and are not being contested in good faith, except where the failure to
file or pay would not reasonably be expected to have a Material Adverse Effect. Except as otherwise disclosed in or contemplated by the Registration Statement or the Prospectus, no tax deficiency has been determined adversely to the Company or any
Subsidiary which has had, individually or in the aggregate, a Material Adverse Effect. The Company has no knowledge of any federal, state or other governmental tax deficiency, penalty or assessment which has been asserted or threatened against it
which would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) <U>Title to Real and Personal Property</U>. The Company and the Subsidiaries have good
and marketable title to all items of real property owned by them and good and valid title to all personal property described in the Registration Statement or Prospectus as being owned by them that are material to the businesses of the Company or
such Subsidiary, in each case free and clear of all liens, encumbrances and claims, except those that (i)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries or
(ii)&nbsp;would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Any real property described in the Registration Statement or Prospectus as being leased by the Company and the Subsidiaries is held by
them under valid, existing and enforceable leases, except those that (A)&nbsp;do not materially interfere with the use made or proposed to be made of such property by the Company or the Subsidiaries or (B)&nbsp;would not reasonably be expected to
have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) <U>Intellectual Property</U>. To the Company&#8217;s knowledge, the Company and the Subsidiaries own
or possess, or can acquire on reasonable terms, enforceable rights to use all patents, patent applications, trademarks (both registered and unregistered), service marks, trade names, trademark registrations, service mark registrations, copyrights,
licenses and <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures) (collectively, the &#8220;<U>Intellectual
Property</U>&#8221;), necessary for the conduct of their respective businesses as conducted as of the date hereof, except to the extent that the failure to own or possess adequate rights to use such Intellectual Property would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect; neither the Company nor any Subsidiary has received any written notice of any claim of infringement or conflict which asserted Intellectual Property rights of others, which
infringement or conflict, if the subject of an unfavorable decision, would reasonably be expected to result in a Material Adverse Effect; there are no pending, or to the Company&#8217;s knowledge, threatened judicial proceedings or interference
proceedings challenging the Company&#8217;s or any Subsidiary&#8217;s rights in or to or the validity of the scope of any of the Company&#8217;s or any Subsidiary&#8217;s patents, patent applications or proprietary information, except if such
proceedings would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) <U>Environmental
Laws</U>. Except as set forth in the Registration Statement or the Prospectus, the Company and the Subsidiaries (i)&nbsp;are in compliance with any and all applicable federal, state, local and foreign laws, rules, regulations, decisions and orders
relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (collectively, &#8220;<U>Environmental Laws</U>&#8221;); (ii) have received and are in compliance with all
permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses as described in the Registration Statement and the Prospectus; and (iii)&nbsp;have not received notice of any actual or
potential liability for the investigation or remediation of any disposal or release of hazardous or toxic substances or wastes, pollutants or contaminants, except, in the case of any of clauses (i), (ii) or (iii)&nbsp;above, for any such failure to
comply or failure to receive required permits, licenses, other approvals or liability as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) <U>Disclosure Controls</U>. The Company maintains systems of internal controls designed
to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#8217;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of financial statements in
conformity with generally accepted accounting principles and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (iv)&nbsp;the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company is not aware of any material weaknesses in its internal control over financial
reporting (other than as set forth in the Prospectus or the Incorporated Documents). Since the date of the latest audited financial statements of the Company included in the Prospectus, there has been no change in the Company&#8217;s internal
control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting (other than as set forth in the Prospectus). The Company has established
disclosure controls and procedures (as defined in Exchange Act Rules <FONT STYLE="white-space:nowrap">13a-15</FONT> and <FONT STYLE="white-space:nowrap">15d-15)</FONT> for the Company and designed such disclosure controls and procedures to ensure
that material information relating to the Company is made known to the certifying officers by others within those entities, particularly during the period in which the Company&#8217;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> or Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> as the case may be, is being prepared. The Company&#8217;s certifying officers have evaluated the effectiveness of the
Company&#8217;s disclosure controls and procedures as of a date within 90 days prior to the filing date of the Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year most recently ended (such date, the &#8220;<U>Evaluation
Date</U>&#8221;). The Company presented in its Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year most recently ended the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures
based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no significant changes in the Company&#8217;s internal controls or, to the Company&#8217;s knowledge, in other factors that would be reasonably expected
to significantly affect the Company&#8217;s internal controls. To the knowledge of the Company, the Company&#8217;s &#8220;internal controls over financial reporting&#8221; and &#8220;disclosure controls and procedures&#8221; are effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) <U>Sarbanes-Oxley</U>. There has been no failure on the part of the Company or, any of the Company&#8217;s directors or officers, in
their capacities as such, to comply with any applicable provisions of the Sarbanes-Oxley Act and the applicable rules and regulations promulgated thereunder in all material respects. Each of the principal executive officer and the principal
financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company as applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley
Act with respect to all reports, schedules, forms, statements and other documents required to be filed by it or furnished by it to the Commission during the 12 months prior to the date of this Agreement. For purposes of the preceding sentence,
&#8220;principal executive officer&#8221; and &#8220;principal financial officer&#8221; shall have the meanings given to such terms in the Sarbanes-Oxley Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) <U>Finder&#8217;s Fees</U>. Neither the Company nor any Subsidiary has incurred any liability for any finder&#8217;s fees, brokerage
commissions or similar payments in connection with the transactions herein contemplated, except as may otherwise exist with respect to Agent pursuant to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ee) <U>Labor Disputes</U>. No labor disturbance by or dispute with employees of the Company
or any Subsidiary exists or, to the knowledge of the Company, is threatened which would have a Material Adverse Effect </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ff) <U>Investment
Company Act</U>. Neither the Company or any Subsidiary is or, after giving effect to the offering and sale of the Placement Shares, will it be an &#8220;investment company&#8221; or an entity &#8220;controlled&#8221; by an &#8220;investment
company,&#8221; as such terms are defined in the Investment Company Act of 1940, as amended (the &#8220;<U>Investment Company Act</U>&#8221;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(gg) <U>Operations</U>. The operations of the Company and the Subsidiaries are and have been conducted at all times in compliance with
applicable financial record keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions to which the Company or the Subsidiaries are subject, the
rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#8220;<U>Money Laundering Laws</U>&#8221;), except as would not have a
Material Adverse Effect; and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect to the Money Laundering Laws is pending or, to the
knowledge of the Company, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hh) <U><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements</U>. There are no
transactions, arrangements and other relationships between and/or among the Company, and/or, to the knowledge of the Company, any of its affiliates and any unconsolidated entity, including, but not limited to, any structured finance, special purpose
or limited purpose entity (each, an &#8220;<U>Off Balance Sheet Transaction</U>&#8221;) that would reasonably be expected to affect materially the Company&#8217;s liquidity or the availability of or requirements for its capital resources required to
be described in the Prospectus which have not been described as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Other Agreements</U>. The Company is not a party to any
agreement with an agent or underwriter for any other &#8220;at the market&#8221; or continuous equity transaction other than this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(jj) <U>ERISA</U>. To the knowledge of the Company, each material employee benefit plan, within the meaning of Section&nbsp;3(3) of the
Employee Retirement Income Security Act of 1974, as amended (&#8220;<U>ERISA</U>&#8221;), that is maintained, administered or contributed to by the Company or any of its affiliates for employees or former employees of the Company and the
Subsidiaries has been maintained in material compliance with its terms and the requirements of any applicable statutes, orders, rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as amended (the
&#8220;<U>Code</U>&#8221;); no prohibited transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred which would result in a material liability to the Company with respect to any such plan excluding
transactions effected pursuant to a statutory or administrative exemption; and for each such plan that is subject to the funding rules of Section&nbsp;412 of the Code or Section&nbsp;302 of ERISA, no &#8220;accumulated funding deficiency&#8221; as
defined in Section&nbsp;412 of the Code has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued but unpaid contributions) exceeds the present value of all benefits
accrued under such plan determined using reasonable actuarial assumptions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(kk) <U>Forward Looking Statements</U>. No forward-looking statement (within the meaning of
Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act) (a &#8220;<U>Forward Looking Statement</U>&#8221;) contained in the Registration Statement and the Prospectus (i)&nbsp;has been made or reaffirmed without a reasonable
basis or has been disclosed other than in good faith, and (iii)&nbsp;been prepared in accordance with Item 10 of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ll) <U>Agent Purchases</U>. The Company acknowledges and agrees that Agent has informed the Company that the Agent may, to the extent
permitted under the Securities Act and the Exchange Act, purchase and sell Common Stock for its own account while this Agreement is in effect, provided, that (i)&nbsp;no such purchase or sales shall take place while a Placement Notice is in effect
(except to the extent the Agent may engage in sales of Placement Shares purchased or deemed purchased from the Company as a &#8220;riskless principal&#8221; or in a similar capacity) and (ii)&nbsp;the Company shall not be deemed to have authorized
or consented to any such purchases or sales by the Agent. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(mm) <U>Margin Rules</U>. Neither the issuance, sale and delivery of the
Placement Shares nor the application of the proceeds thereof by the Company as described in the Registration Statement and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other
regulation of such Board of Governors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(nn) <U>Insurance</U>. The Company and the Subsidiaries carry, or are covered by, insurance in
such amounts and covering such risks as the Company and the Subsidiaries reasonably believe is adequate for the conduct of their business and as is customary for companies of similar size engaged in similar businesses in similar industries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(oo) <U>No Improper Practices</U>. (i)&nbsp;Neither the Company nor, to the Company&#8217;s knowledge, the Subsidiaries nor any of their
respective executive officers has, in the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution in violation of law) or made any contribution or other payment to any
official of, or candidate for, any federal, state, municipal, or foreign office or other person charged with similar public or quasi-public duty in violation of any law or of the character required to be disclosed in the Prospectus; (ii)&nbsp;no
relationship, direct or indirect, exists between or among the Company or, to the Company&#8217;s knowledge, the Subsidiaries or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or, to the
Company&#8217;s knowledge, the Subsidiaries, on the other hand, that is required by the Securities Act to be described in the Registration Statement and the Prospectus that is not so described; (iii)&nbsp;no relationship, direct or indirect, exists
between or among the Company or the Subsidiaries or, to the Company&#8217;s knowledge, any affiliate of them, on the one hand, and the directors, officers or stockholders of the Company or, to the Company&#8217;s knowledge, the Subsidiaries, on the
other hand, that is required by the rules of FINRA to be described in the Registration Statement and the Prospectus that is not so described; (iv)&nbsp;there are no material outstanding loans or advances or material guarantees of indebtedness by the
Company or, to the Company&#8217;s knowledge, the Subsidiaries to or for the benefit of any of their respective officers or directors or any of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
members of the families of any of them; (v)&nbsp;the Company has not offered, or caused any placement agent to offer, Common Stock to any person with the intent to influence unlawfully (A)&nbsp;a
customer or supplier of the Company or the Subsidiaries to alter the customer&#8217;s or supplier&#8217;s level or type of business with the Company or the Subsidiaries or (B)&nbsp;a trade journalist or publication to write or publish favorable
information about the Company or the Subsidiaries or any of their respective products or services, and, (vi)&nbsp;neither the Company nor the Subsidiaries nor, to the Company&#8217;s knowledge, any employee or agent of the Company or the
Subsidiaries has made any payment of funds of the Company or the Subsidiaries or received or retained any funds in violation of any law, rule or regulation (including, without limitation, the Foreign Corrupt Practices Act of 1977), which payment,
receipt or retention of funds is of a character required to be disclosed in the Registration Statement or the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(pp) <U>Status
Under the Securities Act</U>. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement
Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(qq) <U>No Misstatement or Omission in an Issuer Free Writing Prospectus</U>. Each Issuer Free Writing Prospectus, as of its
issue date and as of each Applicable Time (as defined below), did not, does not and will not, through the completion of the Placement for which such Issuer Free Writing Prospectus is used or deemed used, include any information that conflicted,
conflicts or will conflict with the information contained in the Registration Statement or the Prospectus, including any incorporated document deemed to be a part thereof that has not been superseded or modified. The foregoing sentence does not
apply to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished to the Company by the Agent specifically for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(rr) <U>No Conflicts</U>. Neither the execution of this Agreement by the Company, nor the issuance, offering or sale of the Placement Shares,
nor the consummation of any of the transactions contemplated herein, nor the compliance by the Company with the terms and provisions hereof will conflict with, or will result in a breach of, any of the terms and provisions of, or has constituted or
will constitute a default under, or has resulted in or will result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any contract or other agreement to which the
Company may be bound or to which any of the property or assets of the Company is subject, except (i)&nbsp;such conflicts, breaches or defaults as may have been waived and (ii)&nbsp;such conflicts, breaches and defaults that would not have a Material
Adverse Effect; nor will such action result (x)&nbsp;in any violation of the provisions of the organizational or governing documents of the Company, or (y)&nbsp;in any violation of the provisions of any statute or any order, rule or regulation
applicable to the Company or of any court or of any federal, state or other regulatory authority or other government body having jurisdiction over the Company, other than in each case any such conflict, breach or violation that, individually or in
the aggregate, which would not have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ss) <U>Sanctions</U>. (i)&nbsp;The Company represents that, neither it nor any Subsidiary
(collectively, the &#8220;<U>Entity</U>&#8221;) nor, any director, officer, employee, nor to the Entity&#8217;s knowledge, any agent, affiliate or representative of the Entity, is a government, individual, or entity (in this paragraph (ss),
&#8220;<U>Covered Person</U>&#8221;) that is, or is owned or controlled by a Covered Person that is: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;the subject
of any sanctions administered or enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control (&#8220;<U>OFAC</U>&#8221;), the United Nations Security Council, the European Union, His Majesty&#8217;s Treasury, or other
relevant sanctions authority (collectively, &#8220;<U>Sanctions</U>&#8221;), nor </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;located, organized or resident
in a country or territory that is the subject of Sanctions administered by OFAC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;The Entity represents and
covenants that it will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Covered Person: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A)&nbsp;to fund or facilitate any activities or business of or with any Covered Person or in any country or territory that, at
the time of such funding or facilitation, is the subject of Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B)&nbsp;in any other manner that will result in
a violation of Sanctions by any Covered Person (including any Covered Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;The Entity represents and covenants that, except as detailed in the Prospectus, for the past 5 years, it has not
knowingly engaged in, is not now knowingly engaged in, and will not knowingly engage in, any dealings or transactions with any Covered Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of
Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(tt) <U>Healthcare Laws</U>.<B> </B>The Company has operated its businesses, and its businesses currently are, in compliance
in all material respects with all applicable rules, regulations and policies of the FDA and any applicable foreign regulatory authority or organization. The Company: (i)&nbsp;has not, during the past three (3)&nbsp;years, received any FDA Form 483,
written notice of adverse finding, warning letter, untitled letter or other written correspondence or written notice from the U.S. Food and Drug Administration (the &#8220;<B>FDA</B>&#8221;) or any other similar federal, state, local or foreign
governmental or regulatory authority alleging or asserting material noncompliance with any Health Care Laws (defined above) or any licenses, certificates, approvals, clearances, authorizations, exemptions, permits and supplements or amendments
thereto required by any Health Care Laws to conduct the Company&#8217;s business as described in the Registration Statement or the Prospectus (&#8220;<B>Authorizations</B>&#8221;); (ii) possesses all material Authorizations and such Authorizations
are valid and in full force and effect and the Company is not in material violation of any such Authorizations; (iii)&nbsp;has not received written notice of any pending or completed claim, suit, proceeding, hearing, enforcement, investigation,
arbitration or other action from the FDA or any other federal, state, local or foreign governmental or regulatory authority or third party alleging that any product candidate, operation or activity is in material violation of any Health Care Laws or
material Authorizations and the Company has no knowledge that the FDA or any other federal, state, local or foreign governmental or regulatory authority or third party is considering any such claim, litigation, arbitration, action, suit,
investigation or proceeding; (iv)&nbsp;has not received written notice that the FDA or any other federal, state, local or foreign governmental or regulatory authority has taken, is taking or intends to take action to limit, suspend, materially
modify or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
revoke any material Authorizations and has no knowledge that the FDA or any other federal, state, local or foreign governmental or regulatory authority is considering such action; and
(v)&nbsp;has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Health Care Laws or Authorizations and all such
reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ggg) <U>Clinical Results</U>. The description of the results of the studies, tests and trials contained in the Registration Statement and the
Prospectus are accurate in all material respects and the Company has no knowledge of any other studies, tests or trials, the results of which are materially inconsistent with or would reasonably be expected to call into question in any material
respect the results described in the Registration Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(hhh) <U>Clinical Trials</U>.<B> </B>Any clinical trials
or human and animal studies described in the Registration Statement and the Prospectus were and, if still pending, are being conducted in all material respects in accordance with standard medical and scientific research procedures and all applicable
statutory requirements, rules, regulations and policies of the FDA, including current good clinical practices and Good Laboratory Practices as such terms are understood in the Company&#8217;s industry, including, without limitation, 21 C.F.R. Parts
50, 54, 56, 58, and 312, and all applicable foreign regulatory requirements and standards. Expect as disclosed in the Registration Statement and the Prospectus, the Company has not received any notices or correspondence from the FDA or any other
governmental authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(uu) <U>Data Privacy</U>. The Company is, and since October&nbsp;1, 2017 has been, in compliance with all applicable data privacy and security
laws, statutes, judgements, orders, rules and regulations of any court or arbitrator or any other governmental or regulatory authority and all applicable laws regarding the collection, use, transfer, export, storage, protection, disposal or
disclosure by the Company of Personal Data collected from or provided by third parties (collectively, the &#8220;<B><I>Privacy Laws</I></B>&#8221;), except where the failure to be in compliance would not, individually or in the aggregate, result in
a Material Adverse Effect. The Company has in place, materially complies with, and takes appropriate steps reasonably designed to (i)&nbsp;ensure compliance with its privacy policies and all third-party contractual obligations regarding Personal
Data; and (ii)&nbsp;reasonably protect the security and confidentiality of all Personal Data (collectively, the &#8220;<B><I>Policies</I></B>&#8221;). Since October&nbsp;1, 2017, the Company has provided notice of its privacy policy on its corporate
website, which provides accurate and sufficient notice of Company&#8217;s then-current privacy practices relating to its subject matter. None of such disclosures made or contained in the privacy policies have been deceptive or in violation of any
Privacy Laws or Policies in any material respect. To the knowledge of the Company, the execution, delivery and performance of this Agreement or any other agreement referred to in this Agreement will not result in a breach of violation of any Privacy
Laws or Policies. The Company has not received written notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws and is unaware of any other facts that, individually or in the
aggregate, would reasonably indicate <FONT STYLE="white-space:nowrap">non-compliance</FONT> with any Privacy Laws or Policies. To the Company&#8217;s knowledge, there is no action, suit or proceeding by or before any court or governmental agency,
authority or body pending or threatened alleging <FONT STYLE="white-space:nowrap">non-compliance</FONT> with Privacy Laws or Policies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vv) <U>Stock Transfer Taxes</U>. On each Settlement Date, all stock transfer or other taxes
(other than income taxes) which are required to be paid in connection with the sale and transfer of the Placement Shares to be sold hereunder will be, or will have been, fully paid or provided for by the Company and all laws imposing such taxes will
be or will have been fully complied with in all material respects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ww) <U>IT Systems</U>. (i)(x)There has been no security breach or
attack or other compromise of or relating to any of the Company&#8217;s and its subsidiaries&#8217; information technology and computer systems, networks, hardware, software, data (including the data of their respective customers, employees,
suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (&#8220;<U>IT Systems and Data</U>&#8221;), and (y)&nbsp;the Company and its subsidiaries have not been notified of, and have no knowledge of
any event or condition that would reasonably be expected to result in any security breach, attack or compromise to their IT Systems and Data, (ii)&nbsp;the Company and each of its subsidiaries have complied, and are presently in compliance with, all
applicable laws, statutes or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority and all industry guidelines, standards, internal policies and contractual obligations relating to the privacy and
security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification and (iii)&nbsp;the Company and each of its subsidiaries have implemented backup and disaster recovery
technology consistent with industry standards and practice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate signed by an officer of the Company and delivered to the
Agent or to counsel for the Agent pursuant to or by the express terms of this Agreement shall be deemed to be a representation and warranty by the Company, as applicable, to the Agent as to the matters set forth therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Covenants of the Company</U>. The Company covenants and agrees with Agent that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement Amendments</U>. After the date of this Agreement and during any period in which a Prospectus relating to any
Placement Shares is required to be delivered by Agent under the Securities Act (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), (i)&nbsp;the Company will notify the Agent promptly of
the time when any subsequent amendment to the Registration Statement has been filed with the Commission and/or has become effective or any subsequent supplement to the Prospectus has been filed and of any request by the Commission for any amendment
or supplement to the Registration Statement or Prospectus or for additional information related to the transactions contemplated by this Agreement, (ii)&nbsp;the Company will prepare and file with the Commission, promptly upon the Agent&#8217;s
reasonable request, any amendments or supplements to the Registration Statement or Prospectus that, in the Agent&#8217;s reasonable opinion, may be necessary or advisable in connection with the distribution of the Placement Shares by the Agent
(provided, however, that the failure of the Agent to make such request shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right to rely on the representations and warranties made by the Company in
this Agreement and provided, further, that the only remedy the Agent shall have with respect to the failure to make such filing shall be to cease making sales under this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Agreement until such amendment or supplement is filed); (iii)&nbsp;the Company will not file any amendment or supplement to the Registration Statement or Prospectus, other than documents
incorporated by reference, relating to the Placement Shares or a security convertible into the Placement Shares unless a copy thereof has been submitted to Agent within a reasonable period of time before the filing and the Agent has not reasonably
objected thereto in writing within two (2)&nbsp;Business Days (provided, however, that (A)&nbsp;the failure of the Agent to make such objection shall not relieve the Company of any obligation or liability hereunder, or affect the Agent&#8217;s right
to rely on the representations and warranties made by the Company in this Agreement and (B)&nbsp;the Company has no obligation to provide the Agent any advance copy of such filing or to provide Agent an opportunity to object to such filing if the
filing does not name the Agent or does not relate to the transactions contemplated by this Agreement; and provided, further, that the only remedy Agent shall have with respect to the failure by the Company to obtain such consent shall be to cease
making sales under this Agreement) and the Company will furnish to the Agent at the time of filing thereof a copy of any document that upon filing is deemed to be incorporated by reference into the Registration Statement or Prospectus, except for
those documents available via EDGAR; and (iv)&nbsp;the Company will cause each amendment or supplement to the Prospectus to be filed with the Commission as required pursuant to the applicable paragraph of Rule 424(b) of the Securities Act or, in the
case of any document to be incorporated therein by reference, to be filed with the Commission as required pursuant to the Exchange Act, within the time period prescribed (the determination to file or not file any amendment or supplement with the
Commission under this Section&nbsp;7(a), based on the Company&#8217;s reasonable opinion or reasonable objections, shall be made exclusively by the Company). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Notice of Commission Stop Orders</U>. The Company will advise the Agent, promptly after it receives notice or obtains knowledge
thereof, of the issuance or threatened issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement, of the suspension of the qualification of the Placement Shares for offering or sale in any jurisdiction,
or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially reasonable efforts to prevent the issuance of any stop order or to obtain its withdrawal if such a stop order should be issued. The
Company will advise the Agent promptly after it receives any request by the Commission for any amendments to the Registration Statement or any amendment or supplements to the Prospectus or any Issuer Free Writing Prospectus or for additional
information related to the offering of the Placement Shares or for additional information related to the Registration Statement, the Prospectus or any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Delivery of Prospectus; Subsequent Changes</U>. During any period in which a Prospectus relating to the Placement Shares is required to
be delivered by the Agent under the Securities Act with respect to the offer and sale of the Placement Shares, (including in circumstances where such requirement may be satisfied pursuant to Rule 172 under the Securities Act), the Company will use
its commercially reasonable efforts to comply with all requirements imposed upon it by the Securities Act, as from time to time in force, and to file on or before their respective due dates (taking into account any extensions available under the
Exchange Act) all reports and any definitive proxy or information statements required to be filed by the Company with the Commission pursuant to Sections 13(a), 13(c), 14, 15(d) or any other provision of or under the Exchange Act. If the Company has
omitted any information from the Registration Statement pursuant to Rule 430B under the Securities Act, it will use commercially reasonable efforts to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
comply with the provisions of and make all requisite filings with the Commission pursuant to said Rule 430B and to notify the Agent promptly of all such filings. If during such period any event
occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances then
existing, not misleading, or if during such period it is necessary to amend or supplement the Registration Statement or Prospectus to comply with the Securities Act, the Company will promptly notify the Agent to suspend the offering of Placement
Shares during such period and the Company will promptly amend or supplement the Registration Statement or Prospectus (at the expense of the Company) so as to correct such statement or omission or effect such compliance; provided, however, that the
Company may delay the filing of any amendment or supplement, if in the judgment of the Company, it is in the best interests of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Listing of Placement Shares</U>. During any period in which the Prospectus relating to the Placement Shares is required to be delivered
by the Agent under the Securities Act with respect to the offer and sale of the Placement Shares, the Company will use commercially reasonable efforts to cause the Placement Shares to be listed on the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Delivery of Registration Statement and Prospectus</U>. The Company will furnish to the Agent and its counsel (at the reasonable expense
of the Company) copies of the Registration Statement, the Prospectus (including all documents incorporated by reference therein) and all amendments and supplements to the Registration Statement or Prospectus that are filed with the Commission during
any period in which a Prospectus relating to the Placement Shares is required to be delivered under the Securities Act (including all documents filed with the Commission during such period that are deemed to be incorporated by reference therein), in
each case as soon as reasonably practicable and in such quantities as the Agent may from time to time reasonably request and, at Agent&#8217;s reasonable request, will also furnish copies of the Prospectus to each exchange or market on which sales
of the Placement Shares may be made; provided, however, that the Company shall not be required to furnish any document (other than the Prospectus) to the Agent or its counsel to the extent such document is available on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Earnings Statement</U>. The Company will make generally available to its security holders as soon as practicable, but in any event not
later than 15 months after the end of the Company&#8217;s current fiscal quarter, an earnings statement covering a <FONT STYLE="white-space:nowrap">12-month</FONT> period that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and
Rule 158 under the Securities Act, provided that the Company will be deemed to have furnished such statements to its security holders to the extent they are filed with the Commission on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Use of Proceeds</U>. The Company will use the Net Proceeds as described in the Prospectus in the section entitled &#8220;Use of
Proceeds.&#8221; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Notice of Other Sales</U>. Without prior written notice to Agent, the Company will not, (A)&nbsp;directly or
indirectly, offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement) or securities convertible into or exchangeable for Common
Stock, warrants or any rights to purchase or acquire, Common Stock during the period beginning on the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading Day immediately prior to the date on which any Placement Notice is
delivered to the Agent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
hereunder and ending on the fifth (5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP>) Trading Day immediately following the final Settlement Date with respect to Placement Shares sold
pursuant to such Placement Notice (or, if the Placement Notice has been terminated or suspended prior to the sale of all Placement Shares covered by a Placement Notice, the date of such suspension or termination); and (B)&nbsp;directly or indirectly
in any other &#8220;at the market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Stock (other than the Placement Shares offered pursuant to this Agreement)
or securities convertible into or exchangeable for Common Stock, warrants or any rights to purchase or acquire, Common Stock prior to the termination of this Agreement; provided, however, that such restrictions will not apply in connection with the
Company&#8217;s issuance, grant or sale of (i)&nbsp;Common Stock, restricted stock units, options to purchase Common Stock or Common Stock issuable upon the exercise of options, or the vesting of any of the foregoing, pursuant to any stock option or
benefits plan, stock ownership plan or dividend reinvestment plan (but not Common Stock subject to a waiver to exceed plan limits in its dividend reinvestment plan) of the Company whether now in effect or hereafter implemented, (ii)&nbsp;Common
Stock issuable upon conversion of securities or the exercise of warrants, options, convertible notes or other rights in effect or outstanding, and disclosed in filings by the Company available on EDGAR or otherwise in writing to the Agent and
(iii)&nbsp;Common Stock or securities convertible into or exchangeable for shares of Common Stock issued in privately negotiated transactions to vendors, customers or other commercial or strategic partners or potential commercial or strategic
partners, as consideration for mergers, acquisitions, other business combinations or strategic alliances occurring after the date of this Agreement which are not issued for capital raising purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Change of Circumstances</U>. The Company will, at any time during the pendency of a Placement Notice advise the Agent promptly after it
shall have received notice or obtained knowledge thereof, of any information or fact that would alter or affect in any material respect any opinion, certificate, letter or other document required to be provided to the Agent pursuant to this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Due Diligence Cooperation</U>. The Company will cooperate with any reasonable due diligence review conducted by the
Agent or its representatives in connection with the transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during regular business hours and at the
Company&#8217;s principal offices, as the Agent may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Required Filings Relating to Placement of Placement
Shares</U>. The Company agrees that on such dates as the Securities Act shall require with respect to the Placement Shares, the Company will (i)&nbsp;file a prospectus supplement with the Commission under the applicable paragraph of Rule 424(b)
under the Securities Act (each and every filing under Rule 424(b), a &#8220;<U>Filing Date</U>&#8221;), which prospectus supplement will set forth, within the relevant period, the amount of Placement Shares sold through the Agent, the Net Proceeds
to the Company and the compensation payable by the Company to the Agent with respect to such Placement Shares, and (ii)&nbsp;deliver such number of copies of each such prospectus supplement to each exchange or market on which such sales were
effected as may be required by the rules or regulations of such exchange or market. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Representation Dates; Certificate</U>. On or prior to the date of the first Placement
Notice delivered by the Company to the Agent (such date, the &#8220;<U>First Placement Date</U>&#8221;) and each time the Company: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i)
amends or supplements (other than a prospectus supplement relating solely to an offering of securities other than the Placement Shares) the Registration Statement or the Prospectus relating to the Placement Shares by means of a post-effective
amendment, sticker, or supplement but not by means of incorporation of documents by reference into the Registration Statement or the Prospectus relating to the Placement Shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) files an annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> under the Exchange Act (including any Form <FONT
STYLE="white-space:nowrap">10-K/A</FONT> containing amended financial information or a material amendment to the previously filed Form <FONT STYLE="white-space:nowrap">10-K);</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) files a quarterly report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> under the Exchange Act; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iv) files a current report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> containing amended financial information (other than
information &#8220;furnished&#8221; pursuant to Items 2.02 or 7.01 of <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> or to provide disclosure pursuant to Item 8.01 of Form <FONT STYLE="white-space:nowrap">8-K</FONT> relating to the
reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No.&nbsp;144) under the Exchange Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(each date of filing of one or more of the documents referred to in clauses (i)&nbsp;through (iv) shall be a &#8220;<U>Representation
Date.</U>&#8221;) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the Company shall furnish the Agent (but in the case of clause (iv)&nbsp;above only if the Agent reasonably determines that the
information contained in such Form <FONT STYLE="white-space:nowrap">8-K</FONT> is material) with a certificate dated the Representation Date, in the form attached hereto as Exhibit 7(l). The requirement to provide a certificate under this
Section&nbsp;7(l) shall be waived for any Representation Date occurring at a time at which no Placement Notice is pending, which waiver shall continue until the earlier to occur of the date the Company delivers a Placement Notice hereunder (which
for such calendar quarter shall be considered a Representation Date) and the next occurring Representation Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Placement Shares following a Representation Date when the
Company relied on such waiver and did not provide the Agent with a certificate under this Section&nbsp;7(l), then before the Company delivers the Placement Notice or the Agent sells any Placement Shares, the Company shall provide the Agent with a
certificate, in the form attached hereto as Exhibit 7(l), dated the date of the Placement Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>Legal Opinion and Negative
Assurance Letter</U>. (1)&nbsp;On or before the First Placement Date, the Company shall cause to be furnished to the Agent a written opinion and negative assurance letter of Cooley LLP (&#8220;<U>Company Counsel</U>&#8221;), or other counsel
reasonably satisfactory to the Agent, each in form and substance reasonably satisfactory to Agent and its counsel; and (2)&nbsp;within five (5)&nbsp;Trading Days of each Representation Date with respect to which the Company is obligated to deliver a
certificate in the form attached hereto as Exhibit 7(l) for which no waiver is applicable, the Company shall cause to be furnished to the Agent a negative assurance letter of Company Counsel, or other counsel reasonably satisfactory to the Agent, in
form and substance reasonably satisfactory to Agent and its counsel; <I>provided</I>, <I>however</I>, the Company shall not be required to furnish any such letter if the Company does not intend to deliver a Placement Notice in such calendar quarter
until such time as the Company delivers its next Placement Notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>Comfort Letter</U>. (1)&nbsp;On or before the First Placement Date and
(2)&nbsp;within five (5)&nbsp;Trading Days of each Representation Date, other than pursuant to Section&nbsp;7(l)(iii), with respect to which the Company is obligated to deliver a certificate in the form attached hereto as Exhibit 7(l) for which no
waiver is applicable, the Company shall cause its independent accountants to furnish the Agent letters (the &#8220;<U>Comfort Letters</U>&#8221;), dated the date the Comfort Letter is delivered, which shall meet the requirements set forth in this
Section&nbsp;7(n). The Comfort Letter from the Company&#8217;s independent accountants shall be in a form and substance reasonably satisfactory to the Agent, (i)&nbsp;confirming that they are an independent public accounting firm within the meaning
of the Securities Act and the Public Company Account Oversight Board, (ii)&nbsp;stating, as of such date, the conclusions and findings of such firm with respect to the financial information and other matters ordinarily covered by accountants&#8217;
&#8220;comfort letters&#8221; to underwriters in connection with registered public offerings (the first such letter, the &#8220;<U>Initial Comfort Letter</U>&#8221;) and (iii)&nbsp;updating the Initial Comfort Letter with any information that would
have been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement and the Prospectus, as amended and supplemented to the date of such letter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <U>Market Activities</U>. The Company will not, directly or indirectly, (i)&nbsp;take any action designed to cause or result in, or that
constitutes or would reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of Common Stock or (ii)&nbsp;sell, bid for, or purchase Common Stock in
violation of Regulation M, or pay anyone any compensation for soliciting purchases of the Placement Shares other than the Agent; provided, however, that the Company may bid for and purchase shares of its Common Stock in accordance with Rule <FONT
STYLE="white-space:nowrap">10b-18</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <U>Investment Company Act</U>. The Company will conduct its affairs
in such a manner so as to reasonably ensure that neither it nor the Subsidiaries will be or become, at any time prior to the termination of this Agreement, an &#8220;investment company,&#8221; as such term is defined in the Investment Company Act,
assuming no change in the Commission&#8217;s current interpretation as to entities that are not considered an investment company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q)
<U>No Offer to Sell</U>. Other than the Prospectus and the Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and
representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that
constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <U>Blue Sky and Other Qualifications</U><I>. </I>The Company will use its commercially
reasonable efforts, in cooperation with the Agent, to qualify the Placement Shares for offering and sale, or to obtain an exemption for the Placement Shares to be offered and sold, under the applicable securities laws of such states and other
jurisdictions (domestic or foreign) as the Agent may designate and to maintain such qualifications and exemptions in effect for so long as required for the distribution of the Placement Shares (but in no event for less than one year from the date of
this Agreement); <I>provided</I>, <I>however</I>, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so
qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. In each jurisdiction in which the Placement Shares have been so qualified or exempt, the Company will file such
statements and reports as may be required by the laws of such jurisdiction to continue such qualification or exemption, as the case may be, in effect for so long as required for the distribution of the Placement Shares (but in no event for less than
one year from the date of this Agreement). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) <U>Sarbanes-Oxley Act</U>. The Company will maintain and keep accurate books and records
reflecting its assets and maintain internal accounting controls in a manner designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance
with generally accepted accounting principles and including those policies and procedures that (i)&nbsp;pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of
the Company, (ii)&nbsp;provide reasonable assurance that transactions are recorded as necessary to permit the preparation of the Company&#8217;s financial statements in accordance with generally accepted accounting principles, (iii)&nbsp;that
receipts and expenditures of the Company are being made only in accordance with management&#8217;s and the Company&#8217;s directors&#8217; authorization, and (iv)&nbsp;provide reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use or disposition of the Company&#8217;s assets that could have a material effect on its financial statements. The Company will maintain such controls and other procedures, including, without limitation, those required by
Sections 302 and 906 of the Sarbanes-Oxley Act, and the applicable regulations thereunder that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is
recorded, processed, summarized and reported, within the time periods specified in the Commission&#8217;s rules and forms, including, without limitation, controls and procedures designed to ensure that information required to be disclosed by the
Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive officer and principal financial officer, or persons performing similar
functions, as appropriate to allow timely decisions regarding required disclosure and to ensure that material information relating to the Company is made known to it by others within the organization, particularly during the period in which such
periodic reports are being prepared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Payment of Expenses</U>. The Company will pay all expenses incident to the performance of its
obligations under this Agreement, including (i)&nbsp;the preparation, filing, including any fees required by the Commission, and printing of the Registration Statement (including financial statements and exhibits) as originally filed and of each
amendment and supplement thereto, in such number as the Agent shall reasonably deem necessary, (ii)&nbsp;the printing and delivery to the Agent of this Agreement and such other documents as may be required in connection with the offering, purchase,
sale, issuance or delivery of the Placement Shares, (iii)&nbsp;the fees and disbursements of the counsel, accountants and other advisors to the Company, (iv)&nbsp;the reasonable and documented <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses of Agent, including reasonable and documented fees and disbursements of counsel to the Agent incurred in connection with (a)&nbsp;entering into the transactions contemplated by this
Agreement in an amount not to exceed $75,000 in the aggregate, and (b)&nbsp;in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
an amount not to exceed $15,000 per calendar quarter thereafter payable in connection with each Representation Date with respect to which the Company is obligated to deliver a certificate
pursuant to Section&nbsp;7(l) for which no waiver is applicable excluding the date of this Agreement (v)&nbsp;the printing and delivery to the Agent of copies of any Permitted Issuer Free Writing Prospectus (defined below) and the Prospectus and any
amendments or supplements thereto in such number as the Agent shall deem reasonably necessary, (vi)&nbsp;the preparation, printing and delivery to the Agent of copies of the blue sky survey, (vii)&nbsp;the documented fees and expenses of the
transfer agent and registrar for the Common Stock, (viii)&nbsp;the reasonable and documented fees and expenses incident to any review by FINRA of the terms of the sale of the Placement Shares, including fees and expenses of counsel to the Agent
(subject to the cap, set forth in clause (iv)&nbsp;above), and (ix)&nbsp;the documented fees and expenses incurred in connection with the listing of the Placement Shares on the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Conditions to the Agent&#8217;s Obligations</U>. The obligations of the Agent hereunder with respect to a Placement will be subject to
the continuing accuracy and completeness of the representations and warranties made by the Company herein, to the due performance by the Company of its obligations hereunder, to the completion by the Agent of a due diligence review satisfactory to
it in its reasonable judgment, and to the continuing reasonable satisfaction (or waiver by the Agent in its sole discretion) of the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement Effective</U>. The Registration Statement shall have become effective and shall be available for the sale of all
Placement Shares contemplated to be issued by any Placement Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>No Material Notices</U>. None of the following events shall
have occurred and be continuing: (i)&nbsp;receipt by the Company of any request for additional information from the Commission or any other federal or state governmental authority during the period of effectiveness of the Registration Statement, the
response to which would require any post-effective amendments or supplements to the Registration Statement or the Prospectus; (ii)&nbsp;the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of the Registration Statement or the initiation of any proceedings for that purpose; (iii)&nbsp;receipt by the Company of any notification with respect to the suspension of the qualification or exemption from qualification of any
of the Placement Shares for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; or (iv)&nbsp;the occurrence of any event that makes any statement of material fact made in the Registration Statement or the
Prospectus or any material document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making of any changes in the Registration Statement, the Prospectus or Incorporated Documents so
that, in the case of the Registration Statement, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading and,
that in the case of the Prospectus, it will not contain any materially untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>No Misstatement or Material Omission</U>. The Agent shall not have
advised the Company that the Registration Statement or Prospectus, or any amendment or supplement thereto, contains an untrue statement of fact that in the Agent&#8217;s reasonable opinion, in consultation with outside counsel, is material, or omits
to state a fact that in the Agent&#8217;s reasonable opinion is material and is required to be stated therein or is necessary to make the statements therein not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Material Changes</U>. Except as contemplated in the Prospectus, or disclosed in the
Company&#8217;s reports filed with the Commission, there shall not have been any Material Adverse Effect, or any development that would reasonably be expected to cause a Material Adverse Effect, or a downgrading in or withdrawal of the rating
assigned to any of the Company&#8217;s securities (other than asset backed securities) by any rating organization or a public announcement by any rating organization that it has under surveillance or review its rating of any of the Company&#8217;s
securities (other than asset backed securities), the effect of which, in the case of any such action by a rating organization described above, in the reasonable judgment of the Agent (without relieving the Company of any obligation or liability it
may otherwise have), is so material as to make it impracticable or inadvisable to proceed with the offering of the Placement Shares on the terms and in the manner contemplated in the Prospectus.. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Legal Opinion</U>. The Agent shall have received the opinion and the negative assurance letter of Company Counsel required to be
delivered pursuant to Section&nbsp;7(m) on or before the date on which such delivery of such opinion and letter, as applicable, is required pursuant to Section&nbsp;7(m). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <U>Comfort Letter</U>. The Agent shall have received the Comfort Letter required to be delivered pursuant to Section&nbsp;7(n) on or
before the date on which such delivery of such Comfort Letter is required pursuant to Section&nbsp;7(n). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Representation
Certificate</U>. The Agent shall have received the certificate required to be delivered pursuant to Section&nbsp;7(l) on or before the date on which delivery of such certificate is required pursuant to Section&nbsp;7(l). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <U>Secretary&#8217;s Certificate</U>. On or prior to the first Representation Date, the Agent shall have received a certificate, signed on
behalf of the Company by its corporate Secretary, in form and substance satisfactory to the Agent and its counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>No
Suspension</U>. Trading in the Common Stock shall not have been suspended on the Exchange, and the Common Stock shall not have been delisted from the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <U>Other Materials</U>. On each date on which the Company is required to deliver a certificate pursuant to Section&nbsp;7(l), the Company
shall have furnished to the Agent such appropriate further information, certificates and documents as the Agent may reasonably request. All such opinions, certificates, letters and other documents will be in compliance with the provisions hereof.
The Company will furnish the Agent with such conformed copies of such opinions, certificates, letters and other documents as the Agent shall reasonably request. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <U>Securities Act Filings Made</U>. All filings with the Commission required by Rule 424 under the Securities Act with respect to the
Placement Shares to have been filed prior to the issuance of any Placement Notice hereunder shall have been made within the applicable time period prescribed for such filing by Rule 424. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <U>Approval for Listing</U>. The Placement Shares shall either have been approved for
listing on the Exchange, subject only to notice of issuance, or the Company shall have filed an application for listing of the Placement Shares on the Exchange at, or prior to, the issuance of any Placement Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <U>FINRA</U>. FINRA shall have raised no objection to the terms of this offering and the amount of compensation allowable or payable to
the Agent as described in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <U>No Termination Event</U>. There shall not have occurred any event that would permit the
Agent to terminate this Agreement pursuant to Section&nbsp;12(a). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Company Indemnification</U>. The Company agrees to indemnify and hold harmless the Agent, its partners, members, directors, officers,
employees and agents and each person, if any, who controls the Agent within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, arising out of or based upon any
untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make
the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto), or the
omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, joint or several, to the extent of the aggregate
amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission; provided that (subject to Section&nbsp;10(d) below) any such settlement is effected with the written consent of the Company, which consent shall not unreasonably be delayed or withheld; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) against any and all expense whatsoever, as incurred (including the reasonable and documented fees and disbursements of counsel),
reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or
omission, or any such alleged untrue statement or omission, of the Company to the extent that any such expense is not paid under (i)&nbsp;or (ii)&nbsp;above, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of
any untrue statement or omission or alleged untrue statement or omission made solely in reliance upon and in conformity with written information furnished to the Company by the Agent expressly for use in the Registration Statement (or any amendment
thereto), or in any related Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Agent Indemnification</U>. Agent agrees to indemnify and hold harmless the Company
and its directors and each officer of the Company who signed the Registration Statement, and each person, if any, who (i)&nbsp;controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act or
(ii)&nbsp;is controlled by or is under common control with the Company against any and all loss, liability, claim, damage and expense described in the indemnity contained in Section&nbsp;10(a), as incurred, but only with respect to untrue statements
or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendments thereto) or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with information relating to the
Agent and furnished to the Company in writing by the Agent expressly for use therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Procedure</U>. Any party that proposes to
assert the right to be indemnified under this Section&nbsp;10 will, promptly after receipt of notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this
Section&nbsp;10, notify each such indemnifying party of the commencement of such action, enclosing a copy of all papers served, but the omission so to notify such indemnifying party will not relieve the indemnifying party from (i)&nbsp;any liability
that it may have to any indemnified party otherwise than under this Section&nbsp;10 and (ii)&nbsp;any liability that it may have to any indemnified party under the foregoing provision of this Section&nbsp;10 unless, and only to the extent that, such
omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying party will be
entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other indemnifying
party similarly notified, to assume the defense of the action, with counsel reasonably satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the
indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable and documented costs of investigation subsequently incurred by the indemnified party in connection
with the defense. The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (1)&nbsp;the employment of
counsel by the indemnified party has been authorized in writing by the indemnifying party, (2)&nbsp;the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified
parties that are different from or in addition to those available to the indemnifying party, (3)&nbsp;a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying
party (in which case the indemnifying party will not have the right to direct the defense of such action on behalf of the indemnified party) or (4)&nbsp;the indemnifying party has not in fact employed counsel to assume the defense of such action
within a reasonable time after receiving notice of the commencement of the action, in each of which cases the reasonable and documented fees, disbursements and other charges of counsel will be at the expense of the indemnifying party or parties. It
is understood that the indemnifying party or parties shall not, in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
separate firm admitted to practice in such jurisdiction at any one time for all such indemnified party or parties. All such fees, disbursements and other charges will be reimbursed by the
indemnifying party promptly after the indemnifying party receives a written invoice related to fees, disbursements and other reasonable charges in detail. An indemnifying party will not, in any event, be liable for any settlement of any action or
claim effected without its written consent. No indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or
proceeding relating to the matters contemplated by this Section&nbsp;10 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (1)&nbsp;includes an unconditional release of each indemnified party
from all liability arising out of such litigation, investigation, proceeding or claim and (2)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U>. In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in
the foregoing paragraphs of this Section&nbsp;10 is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or the Agent, the Company and the Agent will contribute to the total losses, claims,
liabilities, expenses and damages (including any investigative, legal and other expenses reasonably incurred and documented in connection with, and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after
deducting any contribution received by the Company from persons other than the Agent, such as persons who control the Company within the meaning of the Securities Act, officers of the Company who signed the Registration Statement and directors of
the Company, who also may be liable for contribution) to which the Company and the Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and the Agent on the other
hand. The relative benefits received by the Company on the one hand and the Agent on the other hand shall be deemed to be in the same proportion as the total net proceeds from the sale of the Placement Shares (before deducting expenses) received by
the Company bear to the total compensation received by the Agent (before deducting expenses) from the sale of Placement Shares on behalf of the Company. If, but only if, the allocation provided by the foregoing sentence is not permitted by
applicable law, the allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and the
Agent, on the other hand, with respect to the statements or omission that resulted in such loss, claim, liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering.
Such relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or
the Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such statement or omission. The Company and the Agent agree that it would not be just and equitable if contributions
pursuant to this Section&nbsp;10(d) were to be determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to herein. The amount paid or payable by an indemnified party
as a result of the loss, claim, liability, expense, or damage, or action in respect thereof, referred to above in this Section&nbsp;10(d) shall be deemed to include, for the purpose of this Section&nbsp;10(d), any legal or other expenses reasonably
incurred by such indemnified party in connection with investigating or defending any such action or claim to the extent consistent with Section&nbsp;10(c) hereof. Notwithstanding the foregoing provisions of this
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Section&nbsp;10(d), the Agent shall not be required to contribute any amount in excess of the commissions received by it under this Agreement and no person found guilty of fraudulent
misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) will be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;10(d), any person who
controls a party to this Agreement within the meaning of the Securities Act, and any officers, directors, partners, employees or agents of the Agent, will have the same rights to contribution as that party, and each director of the Company and each
officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution, promptly after receipt of notice of
commencement of any action against such party in respect of which a claim for contribution may be made under this Section&nbsp;10(d), will notify any such party or parties from whom contribution may be sought, but the omission to so notify will not
relieve that party or parties from whom contribution may be sought from any other obligation it or they may have under this Section&nbsp;10(d) except to the extent that the failure to so notify such other party materially prejudiced the substantive
rights or defenses of the party from whom contribution is sought. Except for a settlement entered into pursuant to the last sentence of Section&nbsp;10(c) hereof, no party will be liable for contribution with respect to any action or claim settled
without its written consent if such consent is required pursuant to Section&nbsp;10(c) hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Additional Covenants</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Representations and Covenants of the Agent</U>. The Agent represents and warrants that it is duly registered as a broker-dealer under
FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and sold, except such states in which the Agent is exempt from registration or such registration is not otherwise
required. The Agent shall continue, for the term of this Agreement, to be duly registered as a broker-dealer under FINRA, the Exchange Act and the applicable statutes and regulations of each state in which the Placement Shares will be offered and
sold, except such states in which the Agent is exempt from registration or such registration is not otherwise required, during the term of this Agreement. The Agent shall comply with all applicable law and regulations in connection with the
transactions contemplated by this Agreement, including the issuance and sale through the Agent of the Placement Shares </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U>Representations and Agreements to Survive </U>Delivery. The indemnity and contribution agreements contained in Section&nbsp;10 of this Agreement and all representations and warranties of the Company herein or in certificates delivered pursuant
hereto shall survive, as of their respective dates, regardless of (i)&nbsp;any investigation made by or on behalf of the Agent, any controlling persons, or the Company (or any of their respective officers, directors or controlling persons),
(ii)&nbsp;delivery and acceptance of the Placement Shares and payment therefor or (iii)&nbsp;any termination of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12.
<U>Termination</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Agent may terminate this Agreement, by written notice to the Company, as hereinafter specified at any time
(1)&nbsp;if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Prospectus, any Material Adverse Effect, or any development that would reasonably be expected to result in a Material
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Adverse Effect has occurred, which in the reasonable judgment of the Agent, is material and adverse and makes it impractical or inadvisable to market the Placement Shares, (2)&nbsp;if there has
occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a
prospective change in national or international political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Agent, impracticable or inadvisable to market the Placement Shares or to
enforce contracts for the sale of the Placement Shares, (3)&nbsp;if trading in the Common Stock has been suspended or limited by the Commission or the Exchange, or if trading generally on the Exchange has been suspended or limited, or minimum prices
for trading have been fixed on the Exchange, (4)&nbsp;if any suspension of trading of any securities of the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market
shall have occurred and be continuing, (5)&nbsp;if a major disruption of securities settlements or clearance services in the United States shall have occurred and be continuing, or (6)&nbsp;if a banking moratorium has been declared by either U.S.
Federal or New York authorities. Any such termination shall be without liability of any party to any other party except that the provisions of Section&nbsp;8 (Expenses), Section&nbsp;10 (Indemnification), Section&nbsp;11 (Survival of
Representations), Section&nbsp;17 (Governing Law; Consent to Jurisdiction) and Section&nbsp;18 (Waiver of Jury Trial) hereof shall remain in full force and effect notwithstanding such termination. If the Agent elects to terminate this Agreement as
provided in this Section&nbsp;12(a), the Agent shall provide the required written notice as specified in Section&nbsp;13 (Notices). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
The Company shall have the right, by giving ten (10)&nbsp;days written notice as hereinafter specified to terminate this Agreement in its sole discretion at any time after the date of this Agreement. Any such termination shall be without liability
of any party to any other party except that the provisions of Section&nbsp;8, Section&nbsp;10, Section&nbsp;11, Section&nbsp;17 and Section&nbsp;18 hereof shall remain in full force and effect notwithstanding such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Agent shall have the right, by giving ten (10)&nbsp;days written notice as hereinafter specified to terminate this Agreement in its
sole discretion at any time after the date of this Agreement. Any such termination shall be without liability of any party to any other party except that the provisions of Section&nbsp;8, Section&nbsp;10, Section&nbsp;11, Section&nbsp;17 and
Section&nbsp;18 hereof shall remain in full force and effect notwithstanding such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Unless earlier terminated pursuant to
this Section&nbsp;12, this Agreement shall automatically terminate upon the issuance and sale of all of the Placement Shares through the Agent on the terms and subject to the conditions set forth herein; provided that the provisions of
Section&nbsp;8, Section&nbsp;10, Section&nbsp;11, Section&nbsp;17 and Section&nbsp;18 hereof shall remain in full force and effect notwithstanding such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) This Agreement shall remain in full force and effect unless terminated pursuant to Sections 12(a), (b), (c), or (d)&nbsp;above or
otherwise by mutual agreement of the parties; provided, however, that any such termination by mutual agreement shall in all cases be deemed to provide that Section&nbsp;8, Section&nbsp;10, Section&nbsp;11, Section&nbsp;17 and Section&nbsp;18 shall
remain in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Any termination of this Agreement shall be effective on the date specified in such
notice of termination; provided, however, that such termination shall not be effective until the close of business on the date of receipt of such notice by the Agent or the Company, as the case may be; provided, further, any termination of this
Agreement in accordance with the terms of Section&nbsp;12(b) or (c)&nbsp;shall not be effective until the date that is ten days after the date of such written notice. If such termination shall occur prior to the Settlement Date for any sale of
Placement Shares, such Placement Shares shall settle in accordance with the provisions of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) Subject to the additional
limitations set forth in Section&nbsp;8 of this Agreement, in the event of termination of this Agreement prior to the sale of any Placement Shares, the Agent shall be entitled only to reimbursement of its <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses actually incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Notices</U>. All notices or other
communications required or permitted to be given by any party to any other party pursuant to the terms of this Agreement shall be in writing, unless otherwise specified, and if sent to the Agent, shall be delivered to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">JonesTrading Institutional Services LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">880 Island Park Drive, 3rd Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Daniel Island, SC 29492 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn:
Burke Cook </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: burke@jonestrading.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Duane Morris&nbsp;LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">22 Vanderbilt </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">335 Madison
Avenue, 23rd Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10017 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: James T. Seery </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
JTSeery@duanemorris.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and if to the Company, shall be delivered to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">IN8bio, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">350 5th Avenue,
Suite 5330 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY 10118 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attention: Patrick McCall </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with a copy to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Cooley LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1299 Pennsylvania
Avenue NW </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite 700 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Washington, District of Columbia 20004-2400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Jaime L. Chase </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
jchase@cooley.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each party to this Agreement may change such address for notices by sending to the parties
to this Agreement written notice of a new address for such purpose. Each such notice or other communication shall be deemed given (i)&nbsp;when delivered personally or by verifiable facsimile transmission (with an original to follow) on or before
4:30&nbsp;p.m., New York City time, on a Business Day (as defined below) or, if such day is not a Business Day, on the next succeeding Business Day, (ii)&nbsp;on the next Business Day after timely delivery to a nationally-recognized overnight
courier and (iii)&nbsp;on the Business Day actually received if deposited in the U.S. mail (certified or registered mail, return receipt requested, postage prepaid). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An electronic communication (&#8220;<U>Electronic Notice</U>&#8221;) shall be deemed written notice for purposes of this Section&nbsp;13 if
sent to the electronic mail address specified by the receiving party under separate cover. Electronic Notice shall be deemed received at the time the party sending Electronic Notice receives verification of receipt by the receiving party. Any party
receiving Electronic Notice may request and shall be entitled to receive the notice on paper, in a nonelectronic form (&#8220;<U>Nonelectronic Notic</U>e&#8221;) which shall be sent to the requesting party within ten (10)&nbsp;days of receipt of the
written request for Nonelectronic Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding
upon the Company and the Agent and their respective successors and the affiliates, controlling persons, officers and directors referred to in Section&nbsp;10 hereof. References to any of the parties contained in this Agreement shall be deemed to
include the successors and permitted assigns of such party. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. Neither party may assign its rights or obligations under this Agreement without the prior written consent of the other party; provided,
however, that the Agent may assign its rights and obligations hereunder to an affiliate thereof without obtaining the Company&#8217;s consent, so long as such affiliate is a registered broker dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Adjustments for Stock Splits</U>. The parties acknowledge and agree that all share-related numbers contained in this Agreement shall be
adjusted to take into account any stock split, stock dividend or similar event effected with respect to the Placement Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.
<U>Entire Agreement; Amendment; Severability</U>. This Agreement (including all schedules and exhibits attached hereto and Placement Notices issued pursuant hereto) constitutes the entire agreement and supersedes all other prior and contemporaneous
agreements and undertakings, both written and oral, among the parties hereto with regard to the subject matter hereof. Neither this Agreement nor any term hereof may be amended except pursuant to a written instrument executed by the Company and the
Agent. In the event that any one or more of the provisions contained herein, or the application thereof in any circumstance, is held invalid, illegal or unenforceable as written by a court of competent jurisdiction, then such provision shall be
given full force and effect to the fullest possible extent that it is valid, legal and enforceable, and the remainder of the terms and provisions herein shall be construed as if such invalid, illegal or unenforceable term or provision was not
contained herein, but only to the extent that giving effect to such provision and the remainder of the terms and provisions hereof shall be in accordance with the intent of the parties as reflected in this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>17. <U>GOVERNING LAW AND TIME; WAIVER OF JURY TRIAL</U>. THIS AGREEMENT SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAWS. SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY
APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <B><U>CONSENT TO JURISDICTION</U></B><B>. EACH PARTY HEREBY IRREVOCABLY SUBMITS TO THE
<FONT STYLE="white-space:nowrap">NON-EXCLUSIVE</FONT> JURISDICTION OF THE STATE AND FEDERAL COURTS SITTING IN THE CITY OF NEW YORK, BOROUGH OF MANHATTAN, FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH ANY TRANSACTION
CONTEMPLATED HEREBY, AND HEREBY IRREVOCABLY WAIVES, AND AGREES NOT TO ASSERT IN ANY SUIT, ACTION OR PROCEEDING, ANY CLAIM THAT IT IS NOT PERSONALLY SUBJECT TO THE JURISDICTION OF ANY SUCH COURT, THAT SUCH SUIT, ACTION OR PROCEEDING IS BROUGHT IN AN
INCONVENIENT FORUM OR THAT THE VENUE OF SUCH SUIT, ACTION OR PROCEEDING IS IMPROPER. EACH PARTY HEREBY IRREVOCABLY WAIVES PERSONAL SERVICE OF PROCESS AND CONSENTS TO PROCESS BEING SERVED IN ANY SUCH SUIT, ACTION OR PROCEEDING BY MAILING A COPY
THEREOF (CERTIFIED OR REGISTERED MAIL, RETURN RECEIPT REQUESTED) TO SUCH PARTY AT THE ADDRESS IN EFFECT FOR NOTICES TO IT UNDER THIS AGREEMENT AND AGREES THAT SUCH SERVICE SHALL CONSTITUTE GOOD AND SUFFICIENT SERVICE OF PROCESS AND NOTICE THEREOF.
NOTHING CONTAINED HEREIN SHALL BE DEEMED TO LIMIT IN ANY WAY ANY RIGHT TO SERVE PROCESS IN ANY MANNER PERMITTED BY LAW.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Use of
Information</U>. The Agent may not use any information gained in connection with this Agreement and the transactions contemplated by this Agreement, including due diligence, to advise any party with respect to transactions not expressly approved by
the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. Delivery of an executed Agreement by one party to the other may be made by facsimile or other electronic transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Effect of Headings</U>. The section and Exhibit&nbsp;headings herein are for convenience only and shall not affect the construction
hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Permitted Free Writing Prospectuses</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company represents, warrants and agrees that, unless it obtains the prior consent of the Agent (which consent shall not be unreasonably
withheld or delayed), and the Agent represents, warrants and agrees that, unless it obtains the prior consent of the Company, it has not made and will not make any offer relating to the Placement Shares that would constitute an Issuer Free Writing
Prospectus, or that would otherwise constitute a &#8220;free writing prospectus,&#8221; as defined in Rule&nbsp;405, required to be filed with the Commission. Any such free writing prospectus consented to by the Agent or by the Company, as the case
may be (a &#8220;<U>Permitted Free Writing Prospectus</U>&#8221;). The Company represents and warrants that it has treated and agrees that it will treat each Permitted Free Writing Prospectus as an &#8220;issuer free writing prospectus,&#8221; as
defined in Rule&nbsp;433, and has complied and will comply with the requirements of Rule&nbsp;433 applicable to any Permitted Free Writing Prospectus, including timely filing with the Commission where required, legending and record keeping. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Absence of Fiduciary Relationship</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company acknowledges and agrees that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Agent is acting solely as agent in connection with the public offering of the Placement Shares and in connection with each transaction
contemplated by this Agreement and the process leading to such transactions, and no fiduciary or advisory relationship between the Company or any of its respective affiliates, stockholders (or other equity holders), creditors or employees or any
other party, on the one hand, and the Agent, on the other hand, has been or will be created in respect of any of the transactions contemplated by this Agreement, irrespective of whether or not the Agent has advised or is advising the Company on
other matters, and the Agent has no obligation to the Company with respect to the transactions contemplated by this Agreement except the obligations expressly set forth in this Agreement; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) it is capable of evaluating and understanding, and understands and accepts, the terms, risks and conditions of the transactions
contemplated by this Agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) the Agent has not provided any legal, accounting, regulatory or tax advice with respect to the
transactions contemplated by this Agreement and it has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) it is aware that the Agent and its affiliates are engaged in a broad range of transactions which may involve interests that differ from
those of the Company and the Agent has no obligation to disclose such interests and transactions to the Company by virtue of any fiduciary, advisory or agency relationship or otherwise; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) it waives, to the fullest extent permitted by law, any claims it may have against the Agent for breach of fiduciary duty or alleged breach
of fiduciary duty in connection with the sale of Placement Shares under this Agreement and agrees that the Agent shall not have any liability (whether direct or indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty
claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, employees or creditors of Company, other than in respect of the Agent&#8217;s obligations under this Agreement and to keep information provided
by the Company to the Agent and the Agent&#8217;s counsel confidential to the extent not otherwise publicly-available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24. <U>Definitions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Agreement, the following terms have the respective meanings set forth below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Affiliate</U>&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by
or is under common control with a Person as such terms are used in and construed under Rule 405 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Applicable Time</U>&#8221; means (i)&nbsp;each Representation Date, (ii)&nbsp;the time of each sale of any Placement Shares pursuant
to this Agreement, and (iii)&nbsp;each Settlement Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Business Day</U>&#8221; shall mean any day on which the Exchange and
commercial banks in the City of New York are open for business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Issuer Free Writing Prospectus</U>&#8221; means any
&#8220;issuer free writing prospectus,&#8221; as defined in Rule&nbsp;433, relating to the Placement Shares that (1)&nbsp;is required to be filed with the Commission by the Company, (2)&nbsp;is a &#8220;road show&#8221; that is a &#8220;written
communication&#8221; within the meaning of Rule&nbsp;433(d)(8)(i) whether or not required to be filed with the Commission, or (3)&nbsp;is exempt from filing pursuant to Rule&nbsp;433(d)(5)(i) because it contains a description of the Placement Shares
or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the Company&#8217;s records pursuant to Rule 433(g) under
the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Person</U>&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Rule 172</U>,&#8221; &#8220;<U>Rule 405</U>,&#8221; &#8220;<U>Rule 415</U>,&#8221; &#8220;<U>Rule 424</U>,&#8221;
&#8220;<U>Rule</U><U></U><U>&nbsp;424(b)</U>,&#8221; &#8220;<U>Rule</U><U></U><U>&nbsp;430B</U>,&#8221; and &#8220;<U>Rule</U><U></U><U>&nbsp;433</U>&#8221; refer to such rules under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Subsidiary</U>&#8221; means any subsidiary of the Company that may be identified on Exhibit 21.1 to the Company&#8217;s Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the most recently ended fiscal year, and shall, where applicable, also include any direct or indirect subsidiary of the Company formed or acquired after the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8220;<U>Trading Day</U>&#8221; means any day on which shares of Common Stock are purchased and sold on the Exchange. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references in this Agreement to financial statements and schedules and other information that is &#8220;contained,&#8221;
&#8220;included&#8221; or &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information that is
incorporated by reference in the Registration Statement or the Prospectus, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All references in this Agreement to the Registration Statement, the Prospectus or any
amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to EDGAR; all references in this Agreement to any Issuer Free Writing Prospectus (other than any Issuer Free Writing Prospectuses
that, pursuant to Rule&nbsp;433, are not required to be filed with the Commission) shall be deemed to include the copy thereof filed with the Commission pursuant to EDGAR; and all references in this Agreement to &#8220;supplements&#8221; to the
Prospectus shall include, without limitation, any supplements, &#8220;wrappers&#8221; or similar materials prepared in connection with any offering, sale or private placement of any Placement Shares by the Agent outside of the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing correctly sets forth the understanding between the Company and the Agent,
please so indicate in the space provided below for that purpose, whereupon this letter shall constitute a binding agreement between the Company and the Agent. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>IN8bio, Inc.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ William Ho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: William Ho</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">ACCEPTED as of the date first-above written:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>JONESTRADING INSTITUTIONAL SERVICES LLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">/s/ Burke Cook</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name: Burke Cook</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title: General Counsel&nbsp;&amp; Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 1 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF PLACEMENT NOTICE </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="93%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">From:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">IN8BIO, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">To:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">JONESTRADING INSTITUTIONAL SERVICES LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Attention: _____________________</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Subject:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Placement Notice</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[&#149;]</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the terms and subject to the conditions contained in the Capital on
Demand<B><SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP></B> Sales Agreement between IN8bio, Inc. (the &#8220;<U>Company</U>&#8221;) and JonesTrading Institutional Services LLC (&#8220;<U>Agent</U>&#8221;), dated June&nbsp;1, 2026, the
Company hereby requests that the Agent sell up to ____________ of the Company&#8217;s Common Stock, $0.0001 par value per share, at a minimum market price of $_______ per share, during the time period beginning [month, day, time] and ending [month,
day, time]. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 2 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Compensation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall pay to the Agent in cash, upon each sale of Placement Shares pursuant to this Agreement, an amount equal to 3.0%<B> </B>of
the gross proceeds from each sale of Placement Shares. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SCHEDULE 3 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notice Parties </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center><DIV STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</DIV></center>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="80%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>The Company</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">William Ho</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Patrick McCall</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>The Agent</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Moe Cohen</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Bryan Turley</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Burke Cook</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ryan Loforte</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Michael Truettner</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[***]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">with a copy to [***]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT 7(l) </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Representation Date Certificate </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>____________________, 20__ </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Representation Date Certificate (this &#8220;<U>Certificate</U>&#8221;) is executed and delivered in connection with Section&nbsp;7(l) of
the Capital on Demand<B><SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP></B> Sales Agreement (the &#8220;<U>Agreement</U>&#8221;), dated June&nbsp;1, 2026, and entered into between IN8bio, Inc. (the &#8220;<U>Company</U>&#8221;) and
JonesTrading Institutional Services LLC. All capitalized terms used but not defined herein shall have the meanings given to such terms in the Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned, a duly appointed and authorized officer of the Company, having made all necessary inquiries to establish the accuracy of the
statements below and having been authorized by the Company to execute this certificate, hereby certifies as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. As of the date of
this Certificate, (i)&nbsp;the Registration Statement does not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading and
(ii)&nbsp;neither the Registration Statement nor the Prospectus contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading and (iii)&nbsp;no event has occurred as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein not untrue or misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Each of the representations and warranties of the Company contained in the Agreement (A)&nbsp;to the extent such representations and
warranties are subject to qualifications and exceptions contained therein relating to materiality or Material Adverse Effect, are true and correct on and as of the date hereof with the same force and effect as if expressly made on and as of the date
hereof, except for those representations and warranties that speak solely as of a specific date and which were true and correct as of such date, and (B)&nbsp;to the extent such representations and warranties are not subject to any qualifications or
exceptions, are true and correct in all material respects as of the date hereof as if made on and as of the date hereof with the same force and effect as if expressly made on and as of the date hereof except for those representations and warranties
that speak solely as of a specific date and which were so true and correct as of such date; and. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. Each of the covenants required to be
performed by the Company in the Agreement on or prior to the date of the Agreement, this Representation Date, and each such other date as set forth in the Agreement, has been duly, timely and fully performed in all material respects and each
condition required to be complied with by the Company on or prior to the date of the Agreement, this Representation Date, and each such other date as set forth in the Agreement has been duly, timely and fully complied with in all material respects.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Subsequent to the date of the most recent financial statements in the Prospectus, there has been no Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. No stop order suspending the effectiveness of the Registration Statement or of any part
thereof has been issued, and no proceedings for that purpose have been instituted or are pending or threatened by any securities or other governmental authority (including, without limitation, the Commission). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. No order suspending the effectiveness of the Registration Statement or the qualification or registration of the Placement Shares under the
applicable securities or blue sky laws of any applicable jurisdiction are in effect and no proceeding for such purpose is pending before, or threatened, to the Company&#8217;s knowledge or in writing by, any applicable securities or other
governmental authority (including, without limitation, the Commission). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned has executed this Representation Date Certificate
as of the date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>IN8BIO, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>inab-20260529.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 12:07:52 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:inab="http://in8bio.com/20260529"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2025"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://in8bio.com/20260529"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" namespace="http://fasb.org/srt/2025" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" namespace="http://xbrl.sec.gov/stpr/2025" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inab-20260529_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="inab-20260529_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>inab-20260529_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 12:07:52 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>inab-20260529_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2606 Build:20260317.3 -->
<!-- Creation date: 6/1/2026 12:07:52 PM Eastern Time -->
<!-- Copyright (c) 2026 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="inab-20260529.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g100941g17t82.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g100941g17t82.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  V (H# 1$  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z "@!B2
MI(6".K%3AL'.#Z&@;36Z'T""@ H * "@ H * /&OC+^U3X3^!WB>UT+7=/UF
M[N[BS6]1].@B>,(SN@!+RJ<YC;MC!'-<&(QM/#RY)I]]/^'/OL@X+S#B/"RQ
M>$G",8R<?><D[I)](O35=3V6N\^!"@ H * "@ H * .!^-?QATGX)^"9]>U-
M3<3,WDV=DC /<S$$A0>P&,D]@.YP#RXBO'#PYY'TW#^0XCB'&QPE#1;RETBN
M_P#DNK^\^)=.7XX?M?W]W<V]_)8^'U8H<SO::;'_ + "Y:4COPY&>2,BOGE]
M:QS;OI]R/Z%JOA7@2G&$X<U7?92J/SULHKYQ3Z7-V7]@7XB>',7^@^*M+.H1
M<KY,\]M)_P !<+USCJ0/>M?[,K1UC)7/-7B;DV+_ '6,PTN1]U&2^:O_ )^A
M]$?LH7_C]?#.NZ+\1&O'U?2+U8(7OL-*T)C!!\P?ZT9SA\G///%>I@G6Y91K
M;H_+.-:>4/%4<5DUO9U(W?+M>[Z?9>VEEZ'N=>D?G(4 % !0 4 % 'YY?\%#
MO^2TZ+_V+\'_ *4W-?+YI_&7I^K/ZE\+/^1+5_Z^R_\ 2('Z&U]0?RT% !0
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MP\9?$L_"[X82307"3&SN+NS<+/<3@'S$23/[M$P=S @Y5N0!SPXK%5*E3V%
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/H *K8R;<G=[CJ!!0!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 29, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001740279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 29,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IN8bio, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-5462585<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">350 5th Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 5330<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(646)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">600-6438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">INAB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d100941d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d100941d8k.htm">d100941d8k.htm</File>
    <File>inab-20260529.xsd</File>
    <File>inab-20260529_lab.xml</File>
    <File>inab-20260529_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d100941d8k.htm": {
   "nsprefix": "inab",
   "nsuri": "http://in8bio.com/20260529",
   "dts": {
    "inline": {
     "local": [
      "d100941d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "inab-20260529.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "inab-20260529_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "inab-20260529_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2026-05-29_to_2026-05-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d100941d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2026-05-29_to_2026-05-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d100941d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://in8bio.com//20260529/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-26-249684-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-26-249684-xbrl.zip
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M_H2$P!(XM/H+@_-0H@YGQ.'2%@S!+.E03VZTKAN7ZE0TZ:M!YI<(=A^GM'7
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MET0-NN%MU\+K8,GFY-J":B[VV?BQE]V[\Q2?>/^'N[M>BBOB)_8I+SU>H7B
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MQ_T[+7%G^:$DYF?P7K'(,,Z&00/T/O^&7P,1L=HI#G?L$%#_52N4CY\^H5S
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M ;-F/C)3]NVE@1$."\P7-"K$RLC9QL!JM!F?'^43V$/75*65;E=ZK_F?-#G
MP$8T5?G-@"]@\&E%Y):[Z_13#0$L&#=T-XU8^7CYMEI^D8M<TCY\]2C/(K*^
M7JG2Z_K65*+6DRC<XJO\C$BGA+=[V,M2# /1@4S%1[$1#(F>-QYULFKF0:+1
M12EY!?$C&DJ79MRD@Y95>2XMQ^VG+5,8:/CRPN]EA,?>OAN\"0B6O-1F,/ P
M6*Y/6F_WQ?5?JVUB].PQR\U0^TTG6NZ#B\*2@TI[I+-$\BSSEFD6EUZ46\62
M*V=ZF!?-7>BQ-5IT&+J5W1JQ1!*[L8>O@=/>85-H=W6G^JVJ=%.*<[TZJ2Z<
M5<=AP!2[?-#HO6-X@Z>5K1M*(,XJ\%K=O431:X21M,;(V[Y/'#5$7F47^7(B
M_VEFF,?.8C#NJ^_=_Z^EFT=WO@7K/JFNZTC7_5:T[\L^2]6;'+/SQBWPQFW7
MBZ(S*2$$K,4=GH2*(GK<9\YPX+"V4$5;UVI5]FX&KA%1CPIEK#W0> >N'1Q?
M.WMP&00:$OKT=*8U7(78\+\(./8E415P0O?E[:>W?X@&LGT8#D(7-+_E*\ZW
M %RQ<(!IO9'.2Q+"L"#Y\P;5'==-['PU OGX"SJ &:=VI2;%4LAR)V/K71$0
MY/Z=!X>#PJ:2&Y0SF"1H1E,L4$]3A4V,<HB0=8,W'=V_CX+2=&)(>>Z7QE+!
M^$9!V(F<3#:ZL]"G+QTM#WF8S=+U&9*?E^)BR&]9+&1-Y".9=REDZ.+!1B;U
MSL5_!8M_K,NAZ^\AJ=X.Q[-3(O0*5^9?CQ[F/]V[F__PPX_9 7@MLXT&2::3
MU6;95^OE)<K!P0<3F#VK3L\07BE=-7L30PLW/-H3B:Y+5M7!H.#GWXI+?OS=
MG_+L[IV[/Y F ;_BTKS6ERM]S&(<AHYNQ89>@:4FRR4BVD1^BB%*"81S]&@K
M/;,I$Y=G9OI(L@&TK_W1W0R6NT2R8Q"INC_KB!BK:C:=!-LJY(WQ50CQTPH&
M3Y#&]=]D6!*K1HWSD-Z &]:6X(?30U3;QRB<0Z>74SGG_:;<EHNE9!30<R=P
M;B>X&$2926 ]VC!=CIL '?0#?@3A#>JN1!QTQEN!7Q0N;<+TP (LEPP J<,"
M<92CDZ9M&_3O8"%+#CXVRA/"488Z4%B^UIR"!P1TJ#QO2+>_&7I]Y]H>.^=@
ML5&O7L\X'/H>=OF$81T]0.)2C34'E+I=)65@ACH,16F)PO<11H>_3IFLGE$.
M*(HFYT;'SGF+V%@^KL^&X;TG*,.&0!C!_JY=?:C#-_E89DI ,-9\10G)_ND%
MY,L?X0W78TLJ4<SE8[1K2;&/GN,\/L1ZKD7D3+/H!JZA&>8,M,@ S )JR"G6
MC&MFAQ":,3:Z^C+N<R?]/@O?*(^)N4C4=FV$Z<,MK"+Y2(.[&.IW1F!KS/C\
MPP>QBKI:;T(,"YL&&M'2PHS('L"0PZ*88?JHZ#78IY14V_!N-Q \.B=)>=HV
M[\OV^^<E#*X%92(\X6?5>I>LL&"  Q'0.1JQ22*&O'GKN>5,2-U"+ EP*/;B
M"0U3,;#P#OG]G,:MOT^##J(T>TH@O&I*"VR6,)E1825M9LXIF<&O!0#==<VL
M(F.48T+@O:']-YR5^:1\MUD,/GZ0 (@-JK5'2> )RW\CC!$7:F2\D4X]Z8I9
M#NQ1-PZ'Z69B;LH7G!(W&34S=>ZMY^TVN?.^^$#>BD?#(>AX-L[K[>"PNX#&
M-W!F/]#:O2L^)$A6MV2XQ";!#)<D=J0=EV9V*"4DJ1U<L+;L-VVMW$(^&AFU
MS/ !3*Z.0] _C@TL6:179GQ)G=DN:2&3YA#RPT45]!!Y+7;&(W(&Y?9D=\0!
MECMI<D4\R6"PH/.Y)1? ';DHIUM<?A+ BB<4&&& 2>3KMP2HFB';0-W0KKA0
MZZ4IY=X[%V\T]:7;6%SE^3Z6T)6L8(]PT LS3"CZK'601PSGB#G/NEAZ5LFN
MXP">&WH8( ^1#5H-6O73B72=^02VW%<9B3[Z%HG^I$KXDI5PU2\IM_BF% 7*
M52;PP^^"H+J*BD;MQ4%)CF)2$+?7=Z!F!5=N15=W6U)%KZ*T+GS/EQ6]@!0A
M_H/1F\%#UCI&]_UK\<YD=/K((PU>[_+],1>=2<P/RKOA+D*E;Z%" 0]7HFP:
MR31 271!O;3T4</":(,J]?%09W!*QZ1QKG:-E3-^@MIV-6O2YGSO,=N8T'B[
ME4RP90SV&F?KC<TOA $XYF3[I]MT<JB3]""#"8,=+-%N HNNQ"LCT<Q-;PWX
MKH4/J\N>V,7C:^TB8[BNO(E-@JL0_86G\0Y>/PE] V;D/Z2XJ"^7&*'<#'76
M3N#B;DF_J DRZH$P6/)6*S\^1FO<DGDHN!$! 5W#9N$FDO+"NQT#-_R/ *65
M(QW.O$3E":XE4GS;\AL<X:;VOSA$;H66W #ZAGP[JXM5:1\5Y\3ME^*_S9KU
MI=2 3B=+BTG;&9/#=;T%)K.&Y0P3((^K*V=M&:"_-C4O D_N^\;_1F#H".6"
M:\1Q02RXWQ!LM8F:PXPN.[Y7!.,X1PS&878P:T@TJO,2PS5AYL8*#K%Q.<GQ
M.9DAX&M_W)9\DC")20;^\8J!&/=SP85]+(-@(6.:J(]EBS1 \C1LP0>EL+'7
MQ[;6^T?6'4J+BL222"VZ RE 4R_0E77*'.4 1%.-:&<[IR?O*YD9)"P15)QY
M^K&$#NX-(IS& Y*Y*,Z;E@1S7LXJ3FGOLL?WX =^E 6H6(>P'U04IS68<Q;^
MA+/&W6 -S)<N8;E0P+J83NP?9]BTN*Q/M3YPT.@DWCKW%UE4=@M11'G3Z4(T
M$<4.U(G;SY%@VOA+MFE*O0I5/03J0$Y6M1 Z##OG+V2M?/';L"BD#NR\:AOQ
M1:>37XD] R]#[]_O2X:8<.%WWI>>@GL$029?% 2QXCS22%T;ST&\&7=&8(R7
M1@%S=Q;E7B&D,6+'/+93HJ=]J9W"LK,-+!HH8G#,SR1"MBA[N2)*OX0,]/Q'
MT<Z;#4-WFP_5C,@&I64X1O6+CN#.:[AL-EQ&*K&2 NO9\.?H(O*74+!=F>Z6
M7D#<.X1ES2A,#B"E5A<SY8*Q]K!L'Z=PF&T? N-#N1IRMPQ'9IN)[;C[KM];
MS!4,^"S;>2FFJ2Q >$LXZ@.8>=.+<>!HXMR]'51'<":#8MX6X3NO.KAC%0KN
MT-R?0 "2S3>,7O2M-X2X0\+Y[C0EVF_88*#T/D5HNS<;9,'\7@\D(Q_(16/8
MXG$COZ2V_!JC4G>_1:4^Z2UV<D*WV'/7!1EYQ"@=-0Q#K8J*6A)UWOQ?L+%3
M:\L73&-I9A8\]T8I]*S3!N;CAB(O47PE("9%A>OH11,).AA]P9:DLUZ44!,A
M!MR[?A95N]C64(.WP>G%NXR\AZ#E(Y]BZ3/O]%>2"T.20T$C65/^.T.55,YM
M5BDJ_(77Z2IS2R1'EL JXE&@I&8X2HK1<?>DJC.]6:EIWB=:.;TDS@T*3=<+
MZ][L$%EIN@$1+JFU %73&94^5/16.DB>2#72O6NJBR3Q7VD7BIBL@6^4A1C>
M71K>=H%;+?> BS9>P/F7NQ06K**-#*6:R>D6GOV,<3J$" Q)X ?&GHF$R=7X
MTA*//-<"O,/;V5L'W+%\T-)&A@H/J89B#Q(6)8I.$ ?TKH\+)4*P+##HU1&[
M"[H4)-F)M<C\4C@8ABV7I1M'<!J4LW=WUK)Z+VFGP>?3Q"$[=B6[SJ8<#C-1
M)2([EE5WAL+M^\-[#2>Q70E[Q!#) "7PAC+IN^%5]XI;1P\L[=[NKSR8PU<.
MXWZ4UEM032RML7;/A)BD\1,8=2U\E#2 3,:6OCEB%!Q%9[G6/W*!XB6CT 0
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M3B\K[3U2FV,%*YS)"LO2&NT5\'B; -)XCEPB1B;WD I++"O0I'/'@0G;=EZ
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MOB<MPJQHVTO#/ZJ-]ZC!D^#.$5/"_5-6J&Z$ 0 _2O<WMX3LWG<*W]OZPB#
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M0IJ=2)U:9*(*?Z1+ CG^2#[/;$N8SG!,L$1V!?>&I"=WG;D\1VP'R\\Q:C7
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M\QZ0^IIPN:%?=U'FCUF#\?E_M6'&'[^%&3^I=7M^+K5H6*+Z3JRS[%WQ05E
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M,?^@#_IKD6@'X^KHUK0'@J@7CA[>'7WC8>Y#;/8T:C0!42'FK(&J7%.)P,*
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MEC%J[2F6V4!$9ZA<(ET2_:_K%^)^?XK@ (Y(K35EAW]QY2Y$MLRUZR['$/0
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M:LDD6, 2V&_:"!3+Z<00/W!3>Z&M',7O!F<G&"8[79PJ'LJ\'Q#=CG)^9MP
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M@6<?J#=7WWGX$<IP[WMB"W>'1M:(QV7LZD &#M'B.VX1<=]N#)[\N_+*B K
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MRB$^84+*X3)8:5UE0G2GU"Q<Z,?*S<I>H]45F>X9Y1E$)'[*0<VIJ;?V*ZT
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MHQGC4' PPE^-0,JLW9%%>AF'-&S.'6AJAV)W"!SAT$BS,#@PM^74<C#@%]:
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M:H<;Z!O9=7!^8.BEL^LUKM#9L:'SXY<1OOT?(Q)7<W(\1;_DP;-?\C&OZ*U
M%Y;E*QK1-2>I-YQN-1XCN#NYIM0='HNQI9Y:5>>QG[]:*2B1=$.=!)TP@\[8
M#7.I&]=H[GHMC4*N?J/3UVR70:X8G;T$.MO[VY70>4M&.258<V845?XCI/.E
M5%0%(P)*#CVJ*%"I5EL"&@D_B& % L+L9.:_;4\0!$B JI7#MP=[_-J;W>FN
M;Q)H&H2C $M *!V!=Z1<JDV8Z"WB[[QDE (FF(H37Y=AC8-;57?A_E C?LQ
M#O!9!8+D/F02R>W'G1Z(5Q/Z-]% U^Q<T8E]D]N=)!S%7V8$H,M9,5^NY@3
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M5A'&"[@?6;6V^#UM05AT1J&#238)!;1CF8.; .L*%*FL,-:ZZ@BVA-09F=F
M5(G6R@CA3/(-J&Q;]KV@>Q#K6*BI3>S8J@W<G<Z3!:->4&5B'J_.A2HDB%\3
MG=<I8 AMB 4H<:(K:JQT!;./%"VT))=(V;A3ZR3HUC8>L*\A=Z/95[AWXS$V
MT?!CBYF4^##M@4G.Q7@STADD<P:0G-Z$!$CB<@+,KT*#'RED369S\YVT.!]/
ME@R_1"L-C/DTPBYDB(B@[])I@[MK]5BC04K^W]C@]IBTS QZ3F1=GDG,DP6C
M&T2:D&75/'&E?V(-6L"9&#?)72X-^5F ["))TF9.,G-Y_]'IY,Z+TER8$LC$
M5&%\%I_]3]:!=OCL0'O,,^RGH_?[K\B(^-#[N=7OMKL?O$[]DU?O-KUA^[3U
MSOM4;\,77N_8^WC>_^P-^^UZ1PZRD_; JW_HMUJG+4P*.JEW.MY1R^.66LUJ
MY>@S-=3H=0?#_GFKZ;6[7KW1Z/6;]6ZC!1,W/(%66OC& ;X!_SX8UH<M_$>W
M]<G[W.O_DQ[KG0^]?NM#O0_=ZM%S9_UVM]$^Z[3HE_"*XTZ[,:1_8'.[WN"L
MU6@?MUL\$/JB6?\,K1S#<* 1W7ZC/?Q,S^QZK7KCQ#NK]^&#DU:_!?UO]_NM
MGWN-^E'G,T_%P%<].#[OP-N'7NM?0QS_6:M_VAX.X7U'G^&,.#N#_L#/:'0^
MS //!<Y1O_WA9$BMX&3"XSRU.#GP5 >&V8'A]1JM5A/7H]YO#_!/G ,81*\/
M8^C4A_@1]<19!?@6^S;LU[N#>F/8AJG'R1FV3L_@-] Y'A=J@*/WZS=87\.+
MCY !&V4"^PLC@,&W!\TV=18EBWIV]'[5:@S.CV"^![(:,(Q5J6G=7G>G]:]&
MYWP RZ@2SNR7NR*(JW7<:K;ZL!J-WGD?7C6 ]<5IAY7"YTAP+$GUO:->OW?^
MX00_/*UW3^K#8;WK>\>R*/7FQW-X55V]"U>[V1Z<G</;<(#GW2;NM#ZV#_/3
M;7&O:)O@L]:B5BL%B^I3GY<(+@D@BLK Z_9H[NN#0:L_5*(W.&\/X2F9C+XE
MA"S C4Z]?0I#J<,OX'_<"LC]H-<%N:8E^0B=5ALD.[?\"EA3FDZ?&Z(/RE^,
M;SFB295>5BNP[WO=GUO=-LH/S.WY*4L]-(9OA6_.28'<H>7V*?P;!G"WG:^'
MZL&D_=QNT%NHP<% *SKH%,FD^ORHA>_"'XC^4Y.PI&?P]M-ZNT.;'QH] WTR
MQ%[!Z[8:L%ZLUD@1?&@/X*"!?^$/?/A@>-[OPA^-5OL,5>;_G8.*:C6WL4OT
M6AZCS%6]V>QC)Z%?K>-C7#J455A5&!R- I:9I3*C9BQ)LE919H5/ M+Z[2$*
M]X=>KTD_&9P?'[<;M' E4\CO]F2X<,&"#TYP(E#>Z^VN"#MT6)\W3>P3G0N=
M]FE;"_.G^F?Z4VM;6@/],GD*MFD7AF<K;U38NZB$UG^C?$-'\7G**=-M W22
M!5;#JPT&4Q9I*+06!A/EB[ZHYY&F<IA'9'Y^'_;4>('%>F"ZA'0QP>L4 A*$
MEO<L=W&WWX3]-YXJ0J@O0/U?_[V^MK?+G"Y468\#*?;GRO527Q?1S/X6Z\O?
MR/J]GZ&IRWH^@QG2=7-D3H@^N'A-P,[B+PSJKK'?Y#I/MTVUC(1/:NZQNYZ"
MS6+WLNFH&<(%WU<=[E*!$+?0/N$I$U8T*-?&!V^'&C?@!JLQ<&)+PVR<A)0!
M:CF_4MD&.%<M=JKP]>5*'E672:2A%%1*N.Y&C&V)]ST37*$@IMSQKO2M4T@.
M'?#(IWC!>O%\P7I4V:R1;)[I*, Q>EL_"7&K@:L*'PGC\]X=M-$$#%RG;[ Z
MM8^883MU?4&D'.JIY?G/>/R%@D6X.>4[IVII,;-!\O&\(.\6@?=,@MN0T:SM
MR->C=U)GAD9S377*A/2(_:?X5PFF1V"O0\5$8=)&"BJ,-9J8I:]!#;?129LX
M<E"MV+AEY!'4/S9E''8SG@1G+[$510-\8QJ1R*QG966 <NLO)B$KE<.]%[X#
MS'Z!V$X3Y6MW@7JLTOJ2]ZDIE;8RQ7.N']6IGZM6Y*#9TD.ZRVZQ$PQ<IHY5
MB+.XP'.B"!QGA8;(/'"YZ7L^L5?VA+E@5-\C7MO5JX(47D7+<G# XH[=)&31
M2/HIM&@&:]1",!$LGDNW(1N)5&*S*T?C0(MR)@W&OI N/B\62#63V.BIR!.C
MN"DH92).QMYU&-Y@-<8&S *NWZI?I JA^C@:+T91 !91/Q1 UJOH9D/@RK;4
M6C&YG"[[KKS@1P2/C*@8CQ #X@E*!$K\%ZE>+<"R]6X6%R!WFN!H*<1G01.T
M[ZR+ GOARZ\D^G@@"C+0^1,VZ;0#WKYT^(HJXE*+ @:.\-X2)[>BU5DL'&IO
MB\50DAR8'TM'_>T\"XIK7L439'PF,%4QF)%<Y]:3+^!<&\&NB12"JDN7,+L5
M6 )%>5!&G*7*]PIXLS1,%D;D!65Y)*K/1?ZW\C;N=Q=,'&18+T.+:@X![ I?
M#NEHC^1?F5"\AXNMKA]$QYH]^_EXMI'YW>J.PDCQ/89D,%]")\? 7%.="E[W
MQ^\V *!QL2UQM5%PP\" EU[X-9@L@KG2P\(\SJ@??N:CU,+CE;I@"D:!<1"E
MUZF*_"KDDP(A6;4]WZV_'GNTG1.9N<F$T81-OLI,H'D1D.Z8-<(\^)5$5$7:
M7)&Z%UPWZ[FY'.DSQ4V')_:WV8J>D/1+5RBCR(TZ2JO*B6 X_C8ABF,EBL&W
M( FSN3P\":FE)^FJ'<Z^!%]8'Q$<?0!V X,E7KK[EJ\0:"PRD*> BX:ILNW&
M$=GEB &/_B--VU660%>H2A![BA C)'2LWD _M;N343N8@QTE\X4NN=?'BV\.
M%Z'!&66.&74^H(W_CMZT$1P>-'X1ZB_UL]%\$3:;II*I*35)+=VS-#&*(IHQ
M<XT.%?0!L O,'+WCA3 ^"\4@/T- ;YF'2DR-4M[.4I8HV][/HB"@FN 1H(K0
M.&&:[9NS(QG'D__N2\<(3A4G+ID[ZTG<L]$\<]QR5EEFB(J//4Z4M2X$3DP
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M?QI2;6.CU>D,SNJ-=O?#__YI[T_T[[-ZLZG^+>)SB-)SU.LW6WWZ6'K%G^R
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M;E26*H#4192&U 2##213SM?%*K4\ ,R(+@&>TA&IVT& >;%@*&Q30%)=Z((
M^U#$ZV)"=4= :VH=%YSZ)$3B1B=0NE7EPD/C@%Q7^)7-95(XH5B1-O5^BH$R
MJ@\';SZ7FB\7[3M2'[HRI*7OT&U/,ZTUY5Y'HJ[571))D!0H)OV!T]0 :CA
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MVI:JO<"L?X-7)]V;WAPU\X:V_P-02P,$%     @ $5?!7"=8/K&J!@  HDD
M !4   !I;F%B+3(P,C8P-3(Y7VQA8BYX;6S-G&UOVS80Q]\7Z'>X>6\VH+)C
M!TU1HVF1.4D1+$]HW&W8,!2RQ-C$9-(@Y=C^]B/UT,@Q)5/AJ<J+IK)T][_[
M*[]3&-G*AT_K>00/1$C*V7&GWSWH &$!#RF;'G>6TO-E0&D'9.RST(\X(\>=
M#9&=3Q]?O_KPD^?!Z?G%-7@PB^.%'/9ZJ]6J&]Y3)GFTC)6D[ 9\W@//R^-'
MXZ_P1UIN"%](1'Q)8'!T< 2_+6D4#@<'ZL5A_UWWL)@DB*_5(/1C,H2C7K^G
MXZ _&!Z\&[X=P.T5G/DR)H+!F,Y),94O-H).9S'\$OP*2=8I9XQ$$=G .64^
M"Z@?P5W>[QNX8$$73J((ON@TJ9J41#R0L)NI1I3]-]1?)KIU>/T*0)U#)I-]
MQQU])K(3L9Z(J,O%5#5[<-C+4SJ/&>N=E-5ADM!___Y]+SE:C);4%*O$^[V_
MKB[O@AF9^YXZ]^I[%61E)!W*9/\E#Y)3:-$@E$;H5UX>YNE=7G_@'?:[:QEV
M/NJ"V=GQ)R2Z5%N0>!@*'I&*POIP4KV3Q<>;A8HGZYBPD&3*W[5YD$7-!+E/
M535YB:0D07?*'WHAH9J0MWK#TQNZPY_5BV\CKF _F<A8^$&\72_2IXB+?&=B
MXKAC2.IM-Z3C3D2PI>6+(-=1FWO\9Q&]@*OOVR+V$L4\_5[PN;&+K!PW'/P6
M32)CFYHDM:5GFS#OZ]T^KZE0T9@@DB^%PJO.MS;Q\S%1AG]R[7\_]!YKOY16
MU25$DLNZ_;HA>3)7F*M_\7GD3VV1?)+4$I+FUKGAH N2!B$D)+\K@Y9V!K*!
M1HM VG;KAN,9BVF\&:DRPH\NU 5X_3O9V&)9DMP2GM56>$60"ZX5@DC8IA4@
M*P%)#5!%G %NL/4BR/7[=T/ZE =+/3=CU;TMR=LY+0%L;)SO'G/!=5<'B=)<
M&+2R,YKX;1:)M.P5!\-;(B@/SUAXJGZ=J<OCD^26P31;X15!&*@:!+&934N
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MWAPQ_\RCM]CR+U!+ 0(4 Q0    ( !%7P5SLP=J4,Q4  (R"   .
M      "  0    !D,3 P.30Q9#AK+FAT;5!+ 0(4 Q0    ( !%7P5P_&'4V
M?*   ,P7 P 1              "  5\5  !D,3 P.30Q9&5X,3 Q+FAT;5!+
M 0(4 Q0    ( !%7P5S>&SC5?0L   XH   0              "  0JV  !D
M,3 P.30Q9&5X-3$N:'1M4$L! A0#%     @ $5?!7)5I'<]J P  A0P  !$
M             ( !M<$  &EN86(M,C R-C U,CDN>'-D4$L! A0#%     @
M$5?!7"=8/K&J!@  HDD  !4              ( !3L4  &EN86(M,C R-C U
M,CE?;&%B+GAM;%!+ 0(4 Q0    ( !%7P5R3=!47V@0  /$M   5
M      "  2O,  !I;F%B+3(P,C8P-3(Y7W!R92YX;6Q02P4&      8 !@!^
) 0  .-$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d100941d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="inab-20260529.xsd" xlink:type="simple"/>
    <context id="duration_2026-05-29_to_2026-05-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001740279</identifier>
        </entity>
        <period>
            <startDate>2026-05-29</startDate>
            <endDate>2026-05-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-320">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2026-05-29_to_2026-05-29"
      id="Hidden_dei_EntityCentralIndexKey">0001740279</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-331">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-332">2026-05-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-333">IN8bio, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-334">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-335">001-39692</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-336">82-5462585</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-337">350 5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-338">Suite 5330</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-339">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-340">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-341">10118</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-342">(646)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-343">600-6438</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-344">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-345">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-346">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-347">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-348">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-349">INAB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-350">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-351">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2026-05-29_to_2026-05-29" id="ixv-352">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
